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Introduction 
 
Headache is one among the most common medical complaints. Various 
forms of headache, properly called headache disorders, are among the most 
common disorders of the nervous system. They are pandemic and, in many 
cases, life-long conditions. Recurrent headache disorders impose a substantial 
burden on headache sufferers, family and society. Almost 90% headache 
cases seen in practice are classified as primary headaches, and they are 
defined as headaches that are not caused by an identifiable underlying 
structural, vascular or systemic illness. Although the epidemiology of 
headache disorders is only partly documented, taken together, headache 
disorders are extraordinarily common.This work of dissertation has been done 
with an aim at documenting the different types of primary headaches, their 
clinical presentations and responses to prophylaxis among patients presented 
to the Neurology Out Patient Department, Govt.Rajaji Hospital, Madurai 
during an one year period. 
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Aims and Objectives 
 
This study is aimed to  
1. To classify and study the incidence of various types of Primary 
Headache among patients presented at Neurology Outpatient 
Department, Govt. Rajaji  Hospital, Madurai. 
2. Study the Clinical Profile of each type of Primary Headache. 
3. Study the various patterns of response to prophylaxis in Migraine.  
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Review of Literature 
Headache or Cephalalgia is a symptom of a number of different 
conditions of the head and neck, caused by benign or at times a medical 
emergency. It ranks among the most common pain complaints. One in three 
persons suffers a severe headache at some point in life.  
History: 
The earliest references date back to a papyrus (ancient medical text 
book) dating as old as 3500 BC in the tomb of Thebes’s mentions that the 
king in the tomb had suffered all his life of a sickness of half head. Headache 
with neuralgia is referred to since the times of ancient Egyptians (1200 BC), 
with Hippocrates (460-377BC) describing the visual aura in migraine and its 
relief through vomiting1. Aretaeus of Cappadocia, in the2nd century 
described a unilateral headache associated with vomiting, with headache-free 
intervals is credited as the "discoverer" of migraine2.Galenus of Pergamon 
used the term "hemicrania" (half-head) and thought there was a connection 
between the stomach and the brain, as nausea and vomiting often 
accompanied an attack2.In the Medieval Ages migraine was recognized as a 
disorder that was treated with hot irons, blood letting and even witchcraft. 
Bibliotheca Anatomica, Medic, Chirurgica, published in London (1712), 
describes five major types of headaches, including "Megrim", recognized later 
as classic migraine2. Graham and Wolffe (1938) advocated ergotamine tart for 
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relieving migraine. Harold Wolffe (1950) developed the experimental 
approach to the study of headache and elaborated the vascular theory of 
migraine2. Harold Wolffe (1950), enunciated a list of pain sensitive 
structures.3,4   
There are references to a number of different classification systems for 
headaches with a rich history. The first recorded system that resembles the 
modern one was published by Thomas Willis, in De Cephalagia in 16724. In 
1787 Christian Baur classified headaches into idiopathic (primary headaches) 
and symptomatic (secondary headaches) and defined 84 categories. NIH 
developed a classification system in 19625.  
Demographics & Etiology: 
Epidemiology: According to IHS, migraine constitutes 16% of primary 
headaches. Migraine afflicts 10-20% of the general population. Worldwide 
15-20% of women and 10-15% of men suffer from migraine. In India, 15-
20% of people suffer from migraine with an adult female: male ratio of 2:1.5 
In childhood migraine, boys and girls are affected equally until puberty. In 
individuals older than 12 years, the prevalence increases in both males and 
females, and the incidence declines in individuals older than 40 years, except 
for women in perimenopause. The overall prevalence is higher in females than 
in males. The female-to-male ratio increases from 2.5:1 at puberty to 3.5:1 at 
age 40 years, after which it declines. The incidence of migraine with aura 
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peaks in boys at around age 5 years and in girls at around age 12-13 years. 
The incidence of migraine without aura peaks in boys at age 10-11 years and 
in girls at age 14-17 years. The incidence of migraine in females of 
reproductive age has increased over the last 20 years, probably due to more 
awareness of the condition. 
Age-Gender Incidence: Migraine is an extremely common condition which 
will affect 12–28% of people at some point in their lives. The one year 
prevalence of migraine ranges from 6–15% in adult men and from 14–35% in 
adult women6. These figures vary substantially with age: approximately 4–5% 
of children aged under 12 suffer from migraine, with little apparent difference 
between boys and girls.  
 
Pathophysiology of Migraine: 
Vascular theory: Migraines can begin when blood vessels in the brain 
contract and expand inappropriately. This may start in the occipital lobe, in 
the back of the brain, as arteries undergo spasm. The reduced flow of blood 
from the occipital lobe triggers the visual aura7.Wolffe et al (1940)3 believed 
that intracranial vasoconstriction is responsible for the aura of migraine and 
that subsequent rebound vasodilatation and activation of perivascular 
nociceptive nerves resulted in headache, based on the observations that (1) 
extracranial vessels become distended and pulsatile during a migraine attack, 
(2) stimulation of intracranial vessels in an awake person induces headache, 
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and (3) vasoconstrictors (e.g. ergots) improve the headache, whereas 
vasodilators (e.g. nitroglycerin) provoke an attack.8This theory has fallen out 
of favour, migraine is now considered due to neuronal dysfunction while the 
vascular changes being secondary to neuronal dysfunction. 
 
Depolarization theory: A phenomenon known as cortical spreading 
depression can cause migraines.9In cortical spreading depression, neurological 
activity is depressed over an area of the cortex of the brain. This situation 
results in the release of inflammatory mediators leading to irritation of cranial 
nerve roots, most particularly the trigeminal nerve, which conveys the sensory 
information for the face and much of the head. A spreading depolarization 
may begin 24 hours before the attack, with onset of the headache occurring 
around the time when the largest area of the brain is depolarized. A French 
study in 2007, using the PET technique identified the hypothalamus as being 
critically involved in the early stages.10  
Cortical spreading depression: In 1944, Leao proposed this theory to 
explain the mechanism of migraine with aura. A migraine aura is due to well-
defined wave of neuronal excitation in the cortical gray matter that spreads 
from its site of origin at the rate of 2-6 mm/min; followed by a wave of 
neuronal suppression in a similar fashion. The blood vessels in the area 
simultaneously dilate and constrict. Hence, migraine aura is considered a 
cortical event with definite and well-defined neuroelectrical basis. The 
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neurochemical basis of the CSD is the release of potassium or the excitatory 
amino acid glutamate from neural tissue. This release depolarizes the adjacent 
tissue, which, in turn, releases more neurotransmitters, propagating the 
spreading depression. Positron emission tomography (PET) scanning 
demonstrates that blood flow is moderately reduced during a migrainous aura, 
but the spreading oligemia does not correspond to vascular territories. Specific 
groups of patients with migraine have a genetic defect leading to a lowered 
threshold for CSD, and this is called familial hemiplegic migraine (FHM). 
However, for the vast majority of patients, a clear metabolic or genetic defect 
that easily explains this neuronal excitability cannot be determined.11 
Other theories: Another theories propose that abnormalities in 
neurotransmitters like serotonin,dopamine and deficiency of magnesium.  
Clinical Features: 
The four phases of a migraine attack listed below are common but not 
necessarily experienced by all migraine sufferers. Additionally, the phases 
experienced and the symptoms experienced during them can vary from one 
migraine attack to another. 
 
Prodrome phase: Prodromal symptoms occur in 40–60% of migraineurs 
(migraine sufferers). This phase may consist of altered mood, irritability, 
depression or euphoria, fatigue, yawning, excessive sleepiness, craving for 
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certain food (e.g. chocolate), stiff muscles (especially in the neck), 
constipation or diarrhea, increased urination, and other visceral 
symptoms12.These symptoms usually precede the headache phase of the 
migraine attack by several hours or days, and experience teaches the patient or 
observant family how to detect that a migraine attack is near. 
 
Aura phase: For the 20–30% of individuals who suffer migraine with 
aura, this aura comprises focal neurological phenomena that precede or 
accompany the attack. They appear gradually over 5 to 20 minutes and 
generally last fewer than 60 minutes. The headache phase of the migraine 
attack usually begins within 60 minutes of the end of the aura phase, but it is 
sometimes delayed up to several hours, and it can be missing entirely. 
Symptoms of migraine aura can be visual, sensory, or motor in nature13. 
Visual aura is the most common of the neurological events. There is a 
disturbance of vision consisting usually of unformed flashes of white and/or 
black or rarely of multicolored lights (photopsia) or formations of dazzling 
zigzag lines (scintillating scotoma; often arranged like the battlements of a 
castle, hence the alternative terms "fortification spectra" or "teichopsia". The 
somatosensory aura of migraine consists of feeling of pins-and-needles 
experienced in the hand and arm as well as in the nose-mouth area on the 
same side. 14  
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Pain phase: The typical migraine headache is unilateral, throbbing, moderate 
to severe and can be aggravated by physical activity. Not all of these features 
are necessary. The pain may be bilateral at the onset or start on one side and 
become generalized, and usually alternates sides from one attack to the next. 
The onset is usually gradual. The pain peaks and then subsides, and usually 
lasts between 4 and 72 hours in adults and 1 and 48 hours in children. The 
frequency of attacks is extremely variable. The head pain varies greatly in 
intensity. The pain of migraine is invariably accompanied by other features. 
Many patients experience sensory hyperexcitability manifested by 
photophobia, phonophobia and seek a dark and quiet room. Blurred vision, 
nasal stuffiness, diarrhea, polyuria, pallor or sweating may be noted during the 
headache phase. There may be localized edema of the scalp or face, scalp 
tenderness, prominence of a vein or artery in the temple, or stiffness and 
tenderness of the neck 
 
Postdrome phase: The patient may feel tired, have head pain, cognitive 
difficulties, "hungover", gastrointestinal symptoms, mood changes and 
weakness.15  
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Defining Pain Severity: The IHS defines the intensity of pain with a verbal, 
four-point scale.17 
Number Name Annotations 
0 No pain  
1 Mild pain Does not interfere with usual activities 
2 Moderate pain Inhibits, but does not wholly prevent usual activities
3 Severe pain Prevents all activities 
 
Triggers: A migraine trigger is any factor that, on exposure or withdrawal, 
leads to the development of an acute migraine headache. Triggers may be 
categorized as behavioural, environmental, infectious, dietary, chemical, or 
hormonal. Migraine attacks may be triggered by allergic reactions, bright 
lights, loud noises, and certain odours or perfumes, head trauma, physical or 
emotional stress, changes in sleep patterns, smoking, skipping meals, alcohol, 
menstrual cycle fluctuations, foods containing tyramine, monosodium 
glutamate (MSG) or nitrates, other foods such as chocolate, dairy products, 
and fermented or pickled foods, medications (eg, nitroglycerin, histamine, 
reserpine, hydralazine, ranitidine, estrogen).17 One study found that for some 
migraineurs in India, washing hair in a bath was a migraine trigger. The 
triggering effect was probably due to delayed drying of the wet hair.18   
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Diagnostic Procedures: 
Neuroimaging is indicated for any of the following: [A] First or worst 
headache of the patient's life [B] Change in frequency, severity, or clinical 
features of the headache [C] Abnormal neurological examination [D] 
Progressive or new daily persistent headache [E] Neurological symptoms that 
do not meet the criteria for migraine with typical aura or that themselves 
warrant investigation [E] Persistent neurologic deficit [F] Hemicrania that is 
always on the same side and associated with contralateral neurological 
symptoms [G] Inadequate response to routine therapy [H] Atypical clinical 
presentation. Neuroimaging studies that may be appropriate include CT scan 
and MRI. Other studies such as angiography, MRA, and MRV also may be 
indicated.10  
Electrophysiology: The electroencephalogram (EEG) was a standard 
test for evaluation of headaches in the pre-CT scan era. Gronseth and 
Greenberg [38] reviewed the literature from 1941 to 1994 on the usefulness of 
EEG in the evaluation of patients who had headache. Most of the articles had 
serious methodological flaws. The only significant abnormality reported in 
studies with a relatively nonflawed design was prominent driving in response 
to photic stimulation in migraineurs 9.This finding, although interesting, is not 
necessary for the clinical diagnosis of migraine.  
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Autonomic Function Tests: The rationale to study functions of the 
ANS in headache is primarily based on clinical observations. Changes of ANS 
functions are obvious in cluster headache with autonomic symptoms19 and 
have been extensively investigated for these pains in the last 20 years. 
Changes of ANS function are suspected to be important in migraine but are 
less obvious. 
Treatment:  
Conventional treatment focuses on three areas: trigger avoidance, 
abortive therapy, and prophylaxis. Patients who experience migraines often 
find that the recommended migraine treatments are not 100% effective at 
preventing migraines, and sometimes may not be effective at all. Drug therapy 
is considered effective to reduce the frequency or severity of migraine attacks 
by 50%.20 Children and adolescents are often first given drug treatment, but 
the value of diet modification should not be overlooked.  
I. Abortive Therapy: The abortive treatment of migraine is divided into (1) 
Symptomatic treatment (2) Specific Anti-migraine drugs.  
Non Specific Treatment of Migraine: There is a large group 
nonspecific acute medications for migraine, that include nonsteroidal anti-
inflammatory drugs (NSAIDs), aspirin (ASA), acetaminophen (APAP), 
analgesic combinations with or without caffeine, opioids, butalbital, 
isometheptene, also often in combinations, and medication classes including 
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antihistamines, antinauseants, antiepilepsy drugs, and muscle relaxants. 
Aspirin-acetaminophen-caffeine (AAC) mixtures are Food and Drug 
Administration approved for migraine based on a randomized controlled trial. 
NSAIDs, such as naproxen, diclofenac and solubilized ibuprofen, also are 
superior to placebo in RCTs. Evidence for opioid use in acute migraine 
generally is negative.  
Specific Anti Migraine Treatment: (1) Triptans are serotonin -1B/D 
(5HT1B/D) agonists that work via the serotonin-1D receptors to inhibit CGRP 
and inflammatory peptide release in the meninges and prevent the pain signal 
from returning from the periphery to the trigeminal nucleus caudalis. They 
work via the 5HT1B receptor to constrict vessels dilated by CGRP. Because 
there are some 5HT1B receptors in coronary and other arteries, triptans are 
contraindicated in patients who have vascular disease. Triptans are classified 
into Group I and II. Group-I triptans are fast acting with response rates of two 
hours of medication eg- Sumatriptan, Zolmitriptan, Rizatriptan, Almotriptan 
and Eletriptan. While group II triptans have a minimally slower rate of 
activity at 4 hours eg: Naratriptan and Frovatriptan. Selecting the triptan 
necessitates determining how fast a migraine worsens. If onset is quick, a 
group I triptan is necessary. If emesis is common, a non oral formulation like 
sumatriptan SC or Zolimitriptan Nasal spray are preferred. Some evidence 
suggests a triptan-NSAID combination can reduce headache recurrence.  
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(2) Ergots: Until the introduction of sumatriptan in 1991, ergot 
derivatives were the primary oral drugs available to abort a migraine once it is 
established. Ergot drugs can be used either as a preventive or abortive therapy, 
though their relative expense and cumulative side effects suggest reserving 
them as an abortive rescue medicine. However, ergotamine tartrate tablets 
(usually with caffeine), though highly effective, and long lasting (unlike 
triptans), have fallen out of favour due to the problem of ergotism.21 Both 
ergot and triptans have the same risk for vasoconstriction DHE is tolerated far 
better, is useful as an acute treatment of long migraines because of low 
recurrence, and can be used repetitively for status migrainosus and in 
detoxification from rebound. According to AAN guidelines, maximum dosing 
for DHE is 3 mg per day, up to 21 mg per week. Intranasal DHE dosing 
requires one spray (0.5 mg) into each nostril (without sniffing) at the first sign 
of migraine, followed 15 minutes later by an additional spray into each22  
Other agents: Steroids: Based on a recent meta analysis a single dose of IV 
dexamethasone, when added to standard treatment, is associated with a 26% 
decrease in headache recurrence.23 Recently it has been found that calcitonin 
gene related peptides (CGRPs) play a role in the pathogenesis of the pain 
associated with migraine as triptans also decrease its release and action. 
CGRP receptor antagonists such as olcegepant and telcagepant are being 
investigated both in vitro and in clinical studies for the treatment of migraine.  
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II. Prophylactic Therapy 
US evidence-based guidelines for preventive treatment of migraine include 
the following:  
1. Recurring migraine that significantly interferes with the patient’s daily 
routine despite acute treatment (eg, two or more attacks a month that 
produce disability that lasts 3 or more days, headache attacks that are 
infrequent but produce profound disability  
2. Failure of, contraindication to, or troublesome side effects from acute 
medications  
3. Overuse of acute medications  
4. Special circumstances, such as hemiplegic migraine or attacks with a 
risk for permanent neurologic injury.  
5. Frequent headaches (more than two a week) or a pattern of increasing 
attacks over time, with the risk for developing medication overuse 
headache.  
6. Patient preference, that is, the desire to have as few acute attacks as 
possible   
The major medication groups for preventive migraine treatment include  
1. Anticonvulsants  
2. Antidepressants 
3. Beta-adrenergic blockers 
4. Calcium channel antagonists 
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5. Serotonin antagonists 
6. Botulinum neurotoxins 
7. Nonsteroidal anti-inflammatory drugs 
8. Others - Riboflavin, Magnesium.  
Preventive treatment is often recommended for only 6 to 9 months; 
however, to date, no randomized placebo-controlled trials have been 
performed to investigate migraine frequency after the preventive treatment has 
been discontinued.  
Beta-Adrenergic Blockers: Beta—blockers, the most widely used 
class of drugs in prophylactic migraine treatment, are approximately 50% 
effective in producing a greater than 50% reduction in attack frequency. 
Evidence has consistently demonstrated that non selective beta-blocker 
propranolol is significantly effective, selective b1-blockers metoprolol, 
atenolol, bisoprolol, nadolol, and timolol are also effective, while beta-
blockers with intrinsic sympathomimetic activity (eg, acebutolol, alprenolol, 
oxprenolol, pindolol) are not effective for migraine prevention. Propranolol is 
effective for migraine prevention at a daily dose of 120 to 240 mg, but no 
correlation has been found between its dose and its clinical efficacy.22 The 
action of beta—blockers is probably central and could be mediated by (1) 
inhibiting central b-receptors that interfere with the vigilance-enhancing 
adrenergic pathways, (2) interaction with 5—HT receptors (but not all 
effective beta—blockers bind to the 5—HT receptors), and (3) cross-
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modulation of the serotonin system. Propranolol inhibits nitric oxide (NO) 
production by blocking inducible NO synthase. Propranolol also inhibits 
kainate-induced currents and is synergistic with N-methyl- D-aspartate 
blockers, which reduce neuronal activity and have membrane-stabilizing 
properties23 
Antidepressants: Antidepressants consist of several different drug 
classes with different mechanisms of action. Only one member of the class of 
tricyclic antidepressants, Amitriptyline has proved efficacy in migraine. 
Although the mechanism by which antidepressants work to prevent migraine 
headache is uncertain, it does not result from treating masked depression. 
Antidepressants are useful in treating many chronic pain states, including 
headache, independent of the presence of depression, and the response occurs 
sooner than the expected antidepressant effect. The antidepressants that are 
clinically effective in headache prevention inhibit noradrenaline and 5—HT 
reuptake or are antagonists at the 5—HT2 receptors. The TCA dose range is 
wide and must be individualized. Most TCAs are sedating.  
Calcium Channel Antagonists: The mechanism of action of the 
calcium channel antagonists in migraine prevention is uncertain, but 
possibilities include inhibition of 5—HT release, neurovascular inflammation, 
or the initiation and propagation of cortical spreading depression. Flunarizine, 
a nonselective calcium channel antagonist with antidopaminergic properties, 
was superior to placebo in six of seven randomized clinical trials.24 The dose 
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is 5 to 10 mg given at night, women seem to need lower doses than men. The 
most prominent AEs include weight gain, somnolence, dry mouth, dizziness, 
hypotension, occasional extrapyramidal reactions, and exacerbation of 
depression. Because of its side effects, flunarizine should be considered as a 
second-line drug for migraine prevention, after beta-blockers. Verapamil was 
more effective than placebo in two of three trials, but both positive trials were 
small and dropout rates were high, rendering the findings uncertain. Rigorous 
randomized controlled trial evidence does not exist to support the use of 
verapamil for migraine. Nimodipine, nicardipine, diltiazem, and cyclandelate, 
other nonselective calcium channel antagonists, cannot be recommended for 
migraine prophylaxis.24 
Anticonvulsants: Anticonvulsants are increasingly recommended for 
migraine prevention because of well-conducted placebo-controlled trials. 
With the exception of valproic acid, topiramate, and zonisamide, 
anticonvulsants may substantially interfere with the efficacy of oral 
contraceptives. Carbamazepine 600 to 1200 mg/d, may be effective in 
preventive migraine treatment but it is rarely used in clinical practice for this 
purpose.36 Gabapentin (1800–2400 mg) showed efficacy in a placebo-
controlled double-blind trial, the attack frequency was reduced by 50% in 
approximately one third of patients. Valproic Acid is a simple 8-carbon, 2-
chain fatty acid. Divalproex sodium is a combination of valproic acid and 
sodium valproate. Both are effective as is an extended-release form of 
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divalproex sodium. In 1992, Hering and Kuritzky evaluated the efficacy of 
sodium valproate in migraine treatment in a double-blind, randomized, 
crossover study. Nausea, vomiting, and gastrointestinal distress are the AEs 
that occur most commonly; their incidence decreases, however, particularly 
after 6 months. Later, tremor and alopecia can occur. Valproate has little 
effect on cognitive functions and rarely causes sedation.24 Topiramate: Two 
large, pivotal, multicenter, randomized, double-blind, placebo-controlled 
clinical trials assessed the efficacy and safety of topiramate (50, 100, and 200 
mg/d) in migraine prevention24.The most common AE of topiramate is 
paresthesia; other common AEs are fatigue, decreased appetite, nausea, 
diarrhea, weight loss, taste perversion, hypoesthesia, and abdominal pain. The 
most common central nervous system AEs were somnolence, insomnia, mood 
problems, anxiety, difficulty with memory, language problems, and difficulty 
with concentration. Renal calculi can occur with topiramate use.  
Tension-type headache (TTH) 
 Tension headaches, renamed tension-type headaches by 
the International Headache Society in 1988, are the most common type of 
primary headaches. Tension-type headaches account for nearly 90% of all 
headaches. Approximately 3% of the population suffers from chronic-tension 
type headache. Tension headaches were previously termed as - muscle 
contraction headache, psychomyogenic headache, stress headache, ordinary 
headache, essential headache, idiopathic headache and psychogenic headache. 
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The chronic subtype is a serious disease causing greatly decreased quality of 
life and high disability. The exact mechanisms of tension-type headache are 
not known.  
Pathophysiology: 
Various precipitating factors may cause TTH in susceptible 
individuals [2]. One half of patients with TTH identify stress or hunger as a 
precipitating factor that include - Stress - Usually occurs in the afternoon after 
long stressful work hours, Sleep deprivation & Eyestrain, Uncomfortable 
stressful position and/or bad posture, Irregular meal time (hunger), and 
Caffeine withdrawal. Until recently it was believed that tension headaches 
were caused by muscle tension around the head and neck. Recent research has 
shown that tension headache patients do not have increased muscle tension.25 
Another theory is that the pain may be caused by a malfunctioning pain filter 
which is located in the brain stem. The view is that the brain misinterprets 
information, for example from the temporal muscle or other muscles, and 
interprets this signal as pain. The sensitization of pain pathways may be 
caused by or associated with activation of nitric oxide synthase (NOS) and the 
generation of NO. Patients with chronic tension-type headache have increased 
muscle and skin pain sensitivity, demonstrated by low mechanical, thermal 
and electrical pain thresholds. Hyperexcitability of central 
nociceptive neurons (in trigeminal spinal nucleus, thalamus and cerebral 
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cortex) is believed to be involved in the pathophysiology of chronic tension-
type headache.26  
Frequency: Tension-type headaches can be episodic or chronic. Episodic 
tension-type headaches are defined as tension-type headaches occurring fewer 
than 15 days a month, whereas chronic tension headaches occur 15 days or 
more a month for at least 6 months. Tension-type headaches can last from 
minutes to days, months or even years, though a typical tension headache lasts 
4–6 hours 
Clinical Features: 
Pain onset in tension-type headache can have a throbbing quality and is 
usually more gradual than onset in migraines. Compared with migraines, 
tension-type headaches are more variable in duration, more constant in quality, 
and less severe. Their features are as follows 
o Duration of 30 minutes to 7 days 
o No nausea or vomiting (anorexia may occur) 
o Photophobia and/or phonophobia 
o Minimum of 10 previous headache episodes; fewer than 180 days 
per year with headache to be considered "infrequent" 
o Bilateral and occipitonuchal or bifrontal pain - Pain described as 
"fullness, tightness/squeezing, pressure," or "bandlike/viselike" 
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o May occur acutely under emotional distress or intense worry & 
Insomnia, often present upon rising or shortly thereafter 
o Muscular tightness or stiffness in neck, occipital, and frontal 
regions 
o Duration of more than 5 years in 75% of patients with chronic 
headaches 
o Difficulty concentrating 
o No prodrome 
Physical examination serves mainly to exclude the possibility of other 
headache causes. 
• Vital signs should be normal. 
• Normal neurologic examination 
• Tenderness may be elicited in the scalp or neck, but no other positive 
physical exam findings should be noted. 
• Pain should not be elicited over temporal arteries or positive trigger 
zones. 
• Some patients with occipital tension headaches may be very tender 
when upper cervical muscles are palpated. 
• Pain associated with neck flexion and stretching of paracervical 
muscles must be distinguished from nuchal rigidity associated with 
meningeal irritation. 
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Laboratory Studies: 
Laboratory work should be unremarkable in cases of tension-type 
headache. Specific tests should be obtained if the history or physical 
examination suggests another diagnostic possibility. Head CT scan or MRI is 
necessary only when the headache pattern has changed recently, the headache 
cannot be clearly defined by the clinician as a common primary headache 
disorder or neurologic examination reveals abnormal findings. 
Treatment: 
Nonsteroidal anti-inflammatory drugs (NSAIDs): These agents may 
alleviate headache pain by inhibiting prostaglandin synthesis, reducing 
serotonin release, and blocking platelet aggregation. Although the effects of 
NSAIDs in the treatment of headache pain tend to be patient specific, 
ibuprofen is usually the drug of choice for initial therapy. Other options 
include naproxen, ketoprofen, and ketorolac.27   
 
Physical therapy for patients with headache includes warm and cold 
packs, ultrasound, and electrical stimulation. Regular exercise, stretching, 
balanced meals, and adequate sleep is part of a headache prevention program. 
Trigger point injections, occipital nerve blocks, or changes that improve 
posture may be used. 
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Deterrence/Prevention: Deterrence and prevention of headache may 
include the following: Physical therapy, Biofeedback and relaxation therapy, 
Cervical traction and Injection of trigger points.  
Complications: Complications of headache may include the following: 
Undue reliance on nonprescription caffeine-containing analgesics, 
Dependence on/addiction to narcotic analgesics, GI bleed from use of 
NSAIDs, Risk of epilepsy 4 times greater than that of the general population  
Prognosis: Headache may become chronic if life stressors are not 
changed. Most cases are intermittent and do not interfere with work or normal 
life span. 
Trigeminal autonomic cephalalgias (TAC) 
Cluster headache is a neurological disease that involves, as its most 
prominent feature, an immense degree of pain. "Cluster" refers to the 
tendency of these headaches to occur periodically, with active periods 
interrupted by spontaneous remissions. Cluster headaches have been called by 
several other names in the past including Erythroprosopalgia of Bing, Ciliary 
neuralgia, Erythromelagia of the head, Horton's headache (named after 
Bayard T. Horton, an American neurologist), Histaminic cephalalgia, Petrosal 
neuralgia, sphenopalatine neuralgia, Vidian neuralgia, Sluder's neuralgia, and 
Hemicrania angioparalyticia28. It affects approximately 0.1% of the 
population, and men are more commonly affected than women. The 
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trigeminal autonomic cephalalgias share the clinical features of headache and 
prominent cranial parasympathetic autonomic features.  
Epidemiology: 
Cluster headaches are diagnosed more often in men. The male-to-
female ratio in cluster headache ranges from 4:1 to 7:1. It primarily occurs 
between the ages of 20 to 50 years.29  
Pathophysiology: 
Cluster headaches are caused by the dilation of blood vessels which 
creates pressure on the trigeminal nerve. While this process is the immediate 
cause of the pain, the aetiology is not fully understood. 
Among the most widely accepted theories is that cluster headaches are 
due to an abnormality in the hypothalamus.29Experimental and human 
functional imaging suggests that these syndromes activate a normal human 
trigeminal-parasympathetic reflex with clinical signs of cranial sympathetic 
dysfunction being secondary. 
Genetics: There is a genetic component to cluster headaches, although 
no single gene has been identified as the cause. First-degree relatives of 
sufferers are more likely to have the condition than the population at large. 
  Triggers: Nitroglycerin (glyceryl trinitrate) can sometimes induce 
cluster headaches in sufferers in a manner similar to spontaneous attacks. 
Ingestion of alcohol, chocolate, exposure to hydrocarbons (petroleum solvents, 
perfume), heat, napping, nicotine may trigger cluster headaches.30  
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Clinical Features: 
Cluster headaches are excruciating unilateral headaches of extreme 
intensity. The duration of the common attack ranges from as short as 15 
minutes to three hours or more. The onset of an attack is rapid, and most often 
without the preliminary signs that are characteristic of a migraine. However, 
some sufferers report preliminary sensations of pain in the general area of 
attack, often referred to as "shadows", that may warn them an attack is 
imminent.29 Though the headaches are almost exclusively unilateral, there are 
many documented as cases of "side-shifting" between cluster periods, or, even 
rarer, simultaneously (within the same cluster period) bilateral 
headache Trigeminal neuralgia can also bring on headaches with similar 
qualities. However in Trigeminal neuralgia the pain is mostly located around 
the "cheek" area and is described as being more lance-like in quality. 29 
Pain: The degree of pain involved in cluster headaches is markedly 
greater than in other headache conditions, including severe migraines, and 
experts believe that it may be the most severe pain known to medical science. 
It has been described by female patients as being more severe than 
childbirth.29 The McGill Pain Index can be used to rate levels of pain. The 
pain is lancinating or boring in quality, and is located behind the eye or in the 
temple, sometimes radiating to the neck or shoulder. Analogies frequently 
used to describe the pain are a red-hot poker inserted into the eye, or a spike 
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penetrating from the top of the head, behind one eye, radiating down to the 
neck, or sometimes having a leg amputated without any anaesthetic.   
Cyclical recurrence and regular timing: Cluster headaches are 
occasionally referred to as "alarm clock headaches", because of its ability to 
wake a person from sleep, and because of the regularity of its timing in that 
both the individual attacks and the clusters themselves can have a regularity; 
attacks striking at a precise time of day each morning or night is typical, even 
precisely at the same time a week later.29 
Other symptoms include ptosis, conjunctival injection, lacrimation, 
rhinorrhea, facial blushing, swelling and sweating. These features are known 
autonomic symptoms. The attack is also associated with restlessness, aversion 
to bright lights and loud noise during the attack, nausea is comparatively rare.    
Episodic or Chronic Cluster Headache: occur once or more daily, 
often at the same times each day, for a period of several weeks, followed by a 
headache-free period lasting weeks, months, or years. Cluster headaches 
occurring in two or more cluster periods lasting from 7 to 365 days with a 
pain-free remission of one month or longer between the clusters are 
considered episodic. If the attacks occur for more than a year without a pain-
free remission of at least one month, the condition is considered chronic. 
Chronic clusters run continuously without any "remission" periods between 
cycles. The condition may change from chronic to episodic and from episodic 
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to chronic. Remission periods lasting for decades before the resumption of 
clusters are known to occur.  
Treatment: 
Medications to treat cluster headaches are classified as 
either abortives or prophylactics. In addition, short-term transitional 
medications (such as steroids) may be used while prophylactic treatment is 
instituted and adjusted. With abortive treatments often only decreasing the 
duration of the headache and preventing it from reaching its peak rather than 
eliminating it entirely, preventive treatment is always indicated for cluster 
headaches, to be started at the first sign of a new cluster cycle. 
Abortive treatment: During the onset of a cluster headache, some 
patients respond to rapid inhalation of pure oxygen (12-15 litres per minute in 
a non-rebreathing mask).30 When used at the onset this can abort the attack in 
as little as 1 minute or as long as 10 minutes. Once an attack is at its peak, 
oxygen therapy appears to have little effect.  
Alternative first-line treatment is subcutaneous administration 
of triptan drugs, like  sumatriptan and zolmitriptan. The injectable form of 
sumatriptan has been shown to abort a cluster headache within fifteen minutes 
in 96% of cases. Because of the rapid onset of an attack, the triptan drugs are 
usually taken by subcutaneous injection rather than by mouth. Beta 
blockers as a treatment has been tried. Lidocaine and other topical anesthetics 
 29
sprayed into the nasal cavity may relieve or stop the pain. Vaso-constrictors 
such as ergot compounds were also used. Other abortive remedies that work 
include ice, hot showers, cool or lukewarm water sprayed on the face around 
the sinus, temple, and ear areas, breathing cold air, caffeine, and drinking 
large amounts of water in the early stages of an attack. Hyperbaric oxygen 
therapy has been used successfully in treating cluster headaches though it was 
not shown to be more successful than surface oxygen30.  
Prophylactic Treatment: A wide variety of prophylactic medicines are 
in use, and patient response to these is highly variable. Current European 
guidelines suggest the use of the calcium channel blocker verapamilate at a 
dose of at least 240 mg daily. Steroids, such as prednisolone, are also effective, 
with a high dose given for the first five days or longer before tapering 
down. Methysergide, lithium and the  anticonvulsant  to piramate are 
recommended as alternative treatments. Muscle relaxants and atypical anti-
psychotics have also been used. Magnesium supplements have been shown to 
be of some benefit in about 40% of patients. Melatonin has also been 
demonstrated to bring significant improvement in approximately half of 
episodic patients. Other neuropathic pain alleviating agents such as 
the Tricyclic antidepressants including Amitriptyline and Nortriptyline can 
also be used.30 
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Materials and Methods 
The patients registered at Neurology Outpatient Department, Govt. 
Rajaji Hospital, Madurai  during a one year period between the March 2009 
and February 2010 were taken for this study. The clinical material was 
collected from the records and by patient interviews with a detailed pre-
prepared proforma [Appendix-1]. Antimigraine prophylactic drugs were given 
to patients based on their age, sex and comorbidities. 
Inclusion Criteria: 
1. Patients registered at the Neurology Outpatient Department, Govt. 
Rajaji Hospital, and Madurai during an one year period between the 
March 2009 and February 2010. 
2.  Patients in all age groups in both sexes, of any racial and 
socioeconomic denomination and profession were included 
3. Patients were followed up for one year from the date of their 
registration and those who completed one year of follow up were 
included. All headaches were classified according to the International 
Headache Society Criteria 2004. 
Exclusion Criteria: 
1. Patients with systemic, metabolic, traumatic disorders and or 
radiological findings that were documented to be directly or indirectly 
related to the causation of headache were excluded. 
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2. Headache located or transmitted to the Cranium from the Maxillo / 
Mandibulofacial region, pharynx, paranasal sinuses, neck and ear were 
excluded. 
3. Patients with incomplete clinical profiles, diagnostic & treatment 
records were excluded.  
4. Patients who did not complete the one year follow up were excluded. 
 
Evaluation of Results: 
The clinical presentations, radiological features, laboratory results, 
neurophysiological patterns, treatment and its response on follow up, the 
progress and complications were documented and tabulated in a Master Chart 
(Appendix-2). The various parameters of the patients were compared, 
classified and analysed with specific reference to national and international 
studies.  
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RESULTS      
A total of 502 patients registered at the Headache OPD, 
Department of Neurology, Govt. Rajaji Hospital, Madurai Medical 
College, Madurai between 1st March 2009 and 28th February 2010 were 
included in the study. Of the total of 502 patients, 382 (76.09%) patients 
had migraine, 100 (19.92%) had tension type headache, 12 (2.39%) 
Trigeminal autonomic cephalagia, 8 (1.59%) had other types of primary 
headaches.   
No Type of Primary Headache 
No of 
Patients 
Percentage 
1 Migraine 382 76.09 
2 Tension Type Headache 100 19.92 
3 
Trigeminal autonomic 
cephalalgia 12 
2.39 
4 Other Primary headaches 8 1.59 
  TOTAL NO CASES 502  
 
Classification of Headaches 
Of the 382 case of Migraine, 186(48.69%) patients had Migraine without 
Aura, 36 (9.42%) patients had Migraine with Aura, 90(23.56%) patients 
had Migraine which presented with & without aura, 62(16.23%) patients 
had complications of migraine and 8(2.09%) patients had probable 
migraine.  
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No Type of Migraine IHS Code No of Patients 
1 Migraine without Aura 1.1 186 
2 Migraine with Aura 1.2 36 
3 Migraine with and without aura               1.1 / 1.2 90 
4 Complications of Migraine 1.5 62 
5 Probable Migraine 1.6 8 
  TOTAL  382 
 
Of the patients Migraine with Aura (36 patients) the predominant subtype 
was Typical Aura with Headache (16 patients). Our study also included 6 
patients of Typical Aura with Non Migraine HA, 4 patients with Typical 
Aura without Headache and 10 patients with Basilar Type Migraine. Our 
study group did not have patients with Familial Hemiplegic Migraine and 
Sporadic Hemiplegic Migraine.      
       
No Type of Migraine with Aura 
IHS 
Code 
No of Patients with 
Migraine with Aura 
1 Typical Aura with Headache 1.2.1 16 
2 
Typical Aura with Non 
Migraine HA 1.2.2 6 
3 
Typical Aura without 
Headache 1.2.3 4 
4 Familial Hemiplegic Migraine 1.2.4 0 
5 Sporadic Hemiplegic Migraine 1.2.5 0 
6 Basilar Type Migraine 1.2.6 10 
  TOTAL   36 
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Of the 62 patients with complications of migraine, 48 patients had 
Chronic Migraine (12 patients with Chronic Migraine since Onset & 36 
patients with Episodic Headache converting to Chronic Migraine), 1 
patient had Migrainous Infarction (Right Occipital Infarction) and 13 
patients had Migraine Trigerred Seizures (Migraine Terminating as 
Seizures – 9, Migralepsy-4) 
No 
Type of 
Complications 
of Migraine 
IHS 
Code Sub Types 
No of 
Patients 
Total 
No of 
Patients 
1 
Chronic 
Migraine 
1.5.1
Chronic Migraine  
since Onset 
12 
48 Episodic Headache 
converting to 
Migraine 
36 
2 
Status 
Migrainosus 
 
1.5.2   0 
3 
Persistent 
Aura without 
Infarction 
1.5.3   0 
4 
Migrainous 
Infarction 
1.5.4
Right Occipital 
Infarction 
1 1 
5 
Migraine 
Triggered 
Seizures 
1.5.5
Migraine 
Terminating as 
Seizures 
9 
13 
Migralepsy 4 
 TOTAL    62 
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In our study, we came across 52 patients with Migraine and Seizures, 13 
patients had Migraine Triggered Seizures, 17 patients had Post ictal 
migrainous headache and 22 patients had Migraine & Coexistent Seizure. 
Of the 13 patients who had migraine triggered seizures 9 patients had 
migraine terminating as seizures and 4 patients had Migralepsy. 
 
No Migraine & Seizures No of Patients 
1 Migraine Triggered Seizures 13 
2 Post Ictal Migrainous Headache 17 
3 Migraine & Coexistent Seizure 22 
 
Out of a total of 502 patients registered at the OPD, 100 (19.92%) had 
tension type headache, of which 16 patients had Infrequent Episodic TTH, 
24 patients had Frequent Episodic TTH, 48 patients had Chronic TTH, 
and 12 patients had Probable TTH.  
No Type of TTH IHS Code No of Patients 
1 Infrequent Episodic TTH 2.1 16 
2 Frequent Episodic TTH 2.2 24 
3 Chronic TTH 2.3 48 
4 Probable TTH 2.4 12 
  TOTAL  100 
 
Out of a total of 502 patients registered at the OPD, 12 (2.39%) had 
Trigeminal autonomic cephalagia of which 6 patients had Cluster 
Headache, 5 patients had Paroxysmal hemicrania, 1 patients had Short 
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Lasting Unilateral Neuralgiform Headache with Conjunctival Injection 
and Tearing.  
No Type of Trigeminal Autonomic Cephalalgia 
IHS 
Code 
No of 
Patients 
1 Cluster Headache 3.1 6 
2 Paroxysmal hemicrania 3.2 5 
3 SUNCT 3.3 1 
4 Probable TAC 3.4 0 
 TOTAL  12 
 
Of the 6 patients who had Cluster Headache 4 were classified as Episodic 
Cluster Headache and 2 as Chronic Cluster Headache. Of the 5 patients 
who had Paroxysmal Hemicrania, 3 were classified as Episodic 
Paroxysmal Hemicrania and 2 as Chronic Paroxysmal Hemicrania.  
No Type of Cluster Headache IHS Code No of Patients 
1 Episodic Cluster Headache 3.1.1 4 
2 Chronic Cluster Headache 3.1.2 2 
 TOTAL  6 
 
No Type of TAC IHS 
Code 
No of Patients 
1 Episodic Paroxysmal Hemicrania 3.2.1 3 
2 Chronic Paroxysmal Hemicrania 3.2.2 2 
 TOTAL  5 
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Other Primary headaches were few among the  registered patients at the 
Neurology OPD. 8(1.59%) patients had other primary headaches, of 
which 2 patients had Primary Stabbing Headache, 1 patient had Primary 
Headache associated with Sexual Activity, 1 patient had Primary Hypnic 
Headache, and 4 patients had New Daily Persistent Headache. 
No Other Primary Headaches 
IHS 
Code 
No of 
Patients 
1 Primary Stabbing Headache 4.1 2 
2 Primary Cough Headache 4.2 0 
3 Primary Exertional Headache 4.3 0 
4 
Primary Headache ass with Sexual 
Activity 4.4 1 
5 Primary Hypnic Headache 4.5 1 
6 Primary Thunderclap Headache 4.6 0 
7 Hemicrania Continuua 4.7 0 
8 New Daily Persistent Headache 4.8 4 
 TOTAL  8 
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Epidemiological Data  
The patients were analysed for [1] Age Distribution: 
  No Age Group No of 
Patients 
with 
Migraine 
No of 
Patients with 
TTH 
No of 
Patients 
with TAC 
1 0-10yrs 8 0 0 
2 11-20yrs 139 7 0 
3 21-30yrs 110 19 1 
4 31-40yrs 89 25 9 
5 41-50yrs 26 40 2 
6 51 + yrs 10 9 0 
 
Migraine was most common in the 2nd and 3rd decades, 249 out of 382 
patients were between 11-30years of age (11-20yrs - 139 patients, 21-
30yrs – 110 patients, 31-40yrs – 89 patients). Majority of the patients (65 
out of 100 patients) with Tension type headache were in the 4th and 5th 
decade of life (21-30yrs - 19 patients, 31-40yrs – 25 patients, 41-50yrs – 
40 patients).Trigeminal Autonomic Cephalalgia was more common 
between 31-40years of age - 9 patients. 
 
In patients with migraine triggered seizures of the total 13, 9 
patients were in the age group of 11-20years. Basilar migraine was also 
found to be common in the age group of 11-20years(7 out of 10) patients 
and  Chronic migraine was noticed in 4th and 5th decade of life 
predominantly.(35 out of 48)  
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 [2] Gender Distribution: The patients were analysed for gender 
distribution. Female patients dominated in the category of migraine 262 
of the 402 patients, in tension headache 68 of the 100 patients and while 
in trigeminal autonomic cephalalgia 10 of the 12 patients were male. 
No Sex Distribution Migraine TTH TAC 
1 Male 120 32 10 
2 Female 262 68 2 
  
A complication of migraine was more common in female patients. Out of 
the 13 patients with migraine triggered seizures 10 were female and 3 
were male. Chronic migraine was predominantly seen in females (32 out 
of 48 patients). 
[3] Family Predilection: Family history was positive in 174 patients 
(45.54%) with migraine, 22 patients (22%) with tension headache  and 
none with TAC.     
No Family History Migraine TTH TAC 
1 Positive F.H 174 22 0 
2 Negative. F.H 208 78 12 
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Clinical Presentations 
 
1. Migraine: Headache in patients with migraine, 286 presented with 
unilateral headache, of which 193 patients experienced shift of sides 
while 96 patients had always an unilateral headache. Most of the episodes 
of migrainous headache in our patients lasted more than 12 to 24 hours 
[251 patients]. The migrainous headaches were predominantly temporal 
(217 patients). Most of the patients experienced a throbbing type of 
headache (263 patients). 
No Duration Migraine TTH TAC 
1 1-6 hours 65 19 10 
2 7-12 hours 89 25 2 
3 13-23 hours 145 28 - 
4 More than or equal to 24 hrs 106 28 - 
 
2. Tension Type Headache: In patients with TTH 56 presented with 
headache of more than 12hours duration, while 25 patients had duration 
of 6-12 hours and 19 patients had duration of 1-6hours. 62 of these 
patients who experienced bilateral headaches had headaches confined to 
the frontal region. Most of the patients experienced aching type of 
headache (60 patients), while it was band like in 30 patients. In most of 
these patients the headache radiated to nuchal region and there was 
associated scalp tenderness during the episodes of headache.  
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3. Trigeminal Autonomic Cephalalgia: In patients with Trigeminal 
Autonomic Cephalagia 10 presented with headache of less than 6 hours 
duration, while 2 patients had duration of 6-12 hours. 2 of the patients 
experienced bilateral headaches while 10 had unilateral headaches with 
most (10 patients) confined to the frontal temporal region and was aching 
in character. 
No Location Migraine TTH TAC 
1 Frontal 99 62 0 
2 Temporal 217 18 0 
3 Occipital 40 16 0 
4 Parietal 26 4 2 
5 Fronto Temporal 0 0 10 
 
 
No Type of Headache Migraine TTH TAC 
1 Throbbing 263 7 0 
2 Pricking 56 3 1 
3 Aching 39 60 11 
4 Band Like 0 30 0 
5 Diffuse Dull Ache 14 0 0 
6 Burning 10 0 0 
 
B] Symptoms, Aggravating and Relieving Factors:  
 
1. Migraine: The predominant premonitary symptom was fatigue (76 
patients), followed by, sense of feeling low, irritability, yawning and over 
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eating in few patients. Associated symptoms in order occurrence being 
nausea, photophobia, phonophobia, blurring of vision, vomiting and 
giddiness.  Loss of consciousness was reported in 39 patients. Autonomic 
symptoms like lacrimation, redness and transient syncope were reported 
in few patients. The most common aggravating factor in our study group 
was mental stress, while physical stress, head bath, bright sunlight, lack 
of sleep, travel and consumption of chocolates were also commonly 
reported. Head bath as an aggravating factor has been observed in 116 
patients. The relieving factors were mostly rest and analgesics or topical 
applications and sleep.  
No Premonitary Symptoms Migraine TTH TAC 
1 Yawning 37 1 - 
2 Fatigue 76 14 - 
3 Irritability 39 19 4 
4 Feeling low 64 1 - 
5 Over Eating 22 0 - 
 
2. Tension Type Headache: The predominant premonitary symptom was 
feeling irritability. Associated symptoms being phonophobia (27 patients) 
or photophobia, nausea or vomiting and in few patients paresthesia and 
giddiness.  The most common aggravating factor in our study group was 
mental stress, while physical stress, travel, head bath and lack of sleep 
43 
 
were also commonly reported. The relieving factors were mostly rest and 
analgesics or topical applications, pressure and coffee / tea ingestion.  
    
No 
Associated Symptoms Migraine TTH TAC 
1 Blurring of Vision 322 0 4 
2 Photophobia 365 25 9 
3 Phonophobia 338 25 9 
4 Nausea 368 19 11 
5 Vomiting 158 5 11 
6 Giddiness 148 7 0 
7 Lacrimation 27 1 9 
8 Paresthesia 34 10 0 
9 Tremulousness 38 0 0 
10 Transient LOC 39 0 0 
11 Confusion 19 0 0 
12 Redness of Eyes 16 0 11 
13 Pain ipsilateral limbs 45 0 0 
14 Drooping of eyelids 0 0 7 
15 Nasal Stuffiness 0 0 9 
 
3. Trigeminal Autonomic Cephalagia: The predominant associated 
symptom was nausea, vomiting and redness of eyes (11 patients), with 
nasal stuffiness, phonophobia, photophobia, drooping of eyelids and 
blurring of vision being the other common associated symptoms in order 
of occurrence. Aggravating factors reported this study were alcohol 
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intake, sunlight and lack of sleep. The relieving factors were mostly 
analgesics or topical applications, pressure and coffee / tea ingestion.  
No Aggravating Factors Migraine TTH TAC 
1 Head Bath 116 15 0 
2 Physical Stress 177 22 0 
3 Mental Stress 299 25 0 
4 Sunlight 212 12 1 
5 Travel 187 18 0 
6 Lack of Sleep 269 19 2 
7 Perfumes 62 0 0 
8 Petrol/Diesel Smell 16 0 0 
9 Concentrated Reading 32 4 0 
10 Chocolates 117 0 0 
11 Cold Food/Drink 98 0 0 
12 Close Rooms - Theatre/Auditorium 36 8 0 
13 Alcohol Intake 0 0 3 
 
No Releiving Factors Migraine TTH TAC 
1 Rest & Analgesics 356 37 0 
2 Rest & Topical Applications 126 14 8 
3 Sleep 332 11 1 
4 Rest 112 6 1 
6 Local Pressure 0 26 6 
7 Coffee / Tea 18 16 1 
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C] Aura:  
The preponderant type of aura reported in our migranous patients was 
visual aura in 107 patients while sensory aura was reported in 17 patients 
and both in 2 patients. The visual aura was predominantly in the form of 
flickering of lights in 70 patients, while zig-zag lines, scintillating 
scotomas and fortification spectra was noted in 17 patients, 10 patients 
and 5 patients respectively. The sensory aura seen was commonly in the 
form of paresthesia (12 patients).  
No Aura No of Patients Type of Aura 
1 Visual Aura 102 Fortification Spectra 5 
Scintillating Scotoma 10 
Flickering Lights 70 
Zig Zag Lines 17 
2 Sensory Aura 17 Paresthesia 12 
Numbness 5 
3 Visual & Sensory aura 7  
 
D] Migraine Triggered Seizures: 
Of the 13 patients who had Migraine Triggered Seizures 9 patients had 
Migraine Terminating as Seizures and 4 patients had Migralepsy. On 
analysing the seizure pattern of these 13 patients, 7 patients had GTCS, 6 
patients had CPS.  
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No Migraine Triggered Seizures 
No of 
Patients 
1 GTCS 7 
2 CPS 6 
  
 
 No 
Time between Migraine & onset of 
seizure 
No of Patients 
1 2-3hrs 3 
2 3-6 hrs 6 
3 6-12 hrs  3 
4 >12 hrs  1 
 
E. Associated Conditions:  
1. Migraine: In our study of 382 patients with migraine the following 
clinical conditions were seen associated – namely Healed granulomatous 
lesions on CT, Seizures, Hypertension, and Stroke. 
2. Tension Type Headache: In our study of 35 patients with TTH the 
following clinical conditions were seen associated – namely healed 
granulomatous lesions in CT, Hypertension. 
3. Trigeminal Autonomic Cephalagia:In our study of 12 patients with 
TAC, no significant clinical conditions were associated. 
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No Clinical Diagnosis Migraine TTH TAC 
1 Seizures 52 0 0 
2 Calcified Granuloma on CT 36 16 0 
3 Stroke 3 0 0 
4 Hypertension 30 15 0 
 
Diagnostic Tests 
1. Electrophysiology:  
a) Migraine:  
EEG was taken in 52 of 382 patients with migraine. EEG was taken in all 
the 13 patients with Migraine Triggered Seizures. Changes were seen in 8 
out of 13 patients, 5 patients had spikes and sharp waves in posterior head 
region, 3 patients had non specific slowing in posterior regions and there 
were no specific changes in 5 patients. In other 39 patients, nonspecific 
slowing in posterior regions was seen in 30 patients and EEG was normal 
in 9 patients. 
 
(b) Tension Type Headache: EEG was taken in 9 of the 100 patients 
with TTH, 3 of these patients showed non specific slowing in posterior 
region, while 6 of the patients had no specific changes 
(c) Trigeminal Autonomic Cephalagia: EEG was taken in 2 of the 12 
patients with Cluster Headache and none showed specific changes.  
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No Migraine -EEG Migraine TTH TAC
1 No Changes 14 6 2 
2 Non Specific Slowing in Posterior Region 33 3 0 
3 
Spikes & Sharp Waves in Occipital 
Region 
5 0 0 
 
 2. CT Scan:   
(a) Migraine: CT scan of Brain was taken in all of the 382 patients, 
of whom 40 had changes. The most common change reported in CT scan 
brain was calcified granulomas in 36 patients, gliosis in 3 patients and 
basal ganglia calcification in 1patients. In all the 19 patients with 
Migraine trigerred seizures, CT Scan Brain was found to be normal in all 
patients.  
 
No Migraine Neuro Imaging - CT Brain No of Patients 
1 Normal 342 
2 Abnormal 40 
  Total 382 
 
No CT Brain In Migraine  No of Patients 
1 Calcified Granuloma 36 
2 Gliosis 3 
3 Basal Ganglia Calcification 1 
 TOTAL 40 
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(b) Tension Type Headache: CT scan of brain was taken in all of 
the 100 patients, of whom 18 had changes. The most common change 
reported in CT scan brain was calcified granulomas in 16 patients and 
gliosis in 2 patients..  
 
No CT Brain in TTH No of Patients 
1 Normal 82 
2 Calcified Granuloma 16 
3 Gliosis 2 
 
(c) Trigeminal Autonomic Cephalagia: CT scan of brain was 
taken in all of the 11 patients with none showing abnormality. 
 
Prophylaxis 
1. Migraine: The patients with migraine were given prophylactic 
therapy with either Propronolol (20-160mg), or Amitryptyline(12.5-
50mg), or Propronolol (20-160mg) and Amitryptyline (12.5-50mg) or 
Sodium Valproate (15 to 20mg/kg).  
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No Drugs Patients 
1 Propronolol(20-160mg) 122 
2 Amitryptyline(12.5-50mg) 39 
3 Propronolol (20-160mg)+ Amitryptyline (12.5-50mg) 218 
4 Sodium Valproate (15 to 20 mg / kg) 3 
  TOTAL 382 
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Propronolol(20-
160mg) 
122 15 12 33 27 31 26 43 35 - 
2 
Amitryptyline(12.5-
50mg) 
39 4 10 7 18 9 23 14 36 5 (13%) 
3 
Propronolol (20-
160mg)+ 
Amitryptyline 
(12.5-50mg) 
218 35 16 71 33 62 28 50 23 - 
4 
Sodium Valproate 
(15 to 20 mg / kg) 
3 -  2 67 -  1 33 - 
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2. Migraine Triggered Seizures: All patients were treated with 
anti migrainous prophylaxis with T.Propronolol (40-120mg) and 
analgesics during episodes of headache. Sodium valproate (200mg thrice 
a day) was given to patients who had seizures on follow up. Follow up 
period was 1 year. All patients had 1 year incident free period, while on 
follow up   
 
3. Tension Type Headaches: All patients in our study were treated 
with Amitryptiline (10-50mgms). Of the 100 patients 6 patients 
responded with a disease free interval of 1year, 17 patients with a disease 
free interval of 6 months to 1 year, 35 patients with a disease free interval 
of less than 6months, 34 patients responded with decreased intensity and 
frequency of episodes while 8 patients did not show any response. 
 
4. Trigeminal Autonomic Cephalalgia: One patient with SUNCT 
responded to prophylaxis with sodium valproate with decreased disease 
intensity and frequency. Five patients with paroxysmal hemicrania 
responded well to Indomethacin during acute phases and were given 
prophylaxis with Amitrptiline. Three patients had a disease free interval 
of less than six months and two patients had decreased disease intensity 
and frequency. Prophylaxis was provided for 6 patients with cluster 
headache of which 4 were given Amitryptiline (25-50mgms), 2 patients 
were given Propranolol (80-120mgms). Of the 4 patients given 
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Amitryptiline 3 patients responded with decreased disease intensity and 
frequency, 1 patient with a disease free interval of 6 months to 1 year. Of 
the 2 patients given Propranolol, both of them responded with a disease 
free interval of 1year. 
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DISCUSSION 
This study at the Neurology OPD, Govt. Rajaji Hospital, Madurai 
between 1st March 2009 and 28th February 2010 encompassed a period of 
one year.  
I DEMOGRAPHY OF PRIMARY HEADACHES 
I. INCIDENCE: Of the 502 patients of primary headaches 
included in this study 382 (76.09%) patients had migraine, 100 (19.92) 
had tension type headache, 12 (2.39%) had Trigeminal autonomic 
cephalalgia, 8 (1.57%) had other types of primary headaches. This profile 
of headaches in our study was in inverse correlation with few 
international studies. [Lipton et al 2002].31 Tension type headaches are 
considered the most common form of headache in the general population 
with a prevalance of nearly 80% while the prevalance of migraine is 
pegged at 16% in various international studies31. In contrast, migraine is a 
more common form of headache reported in clinical practice. This 
variance is attributed to self treatment of tension type headaches by the 
general population. This variation reported in our study correlates with 
the study of Lance and Curran [1964] 32 
 A. Incidence of Migraine: In our study of the 382 cases of Migraine, 
186 (48.69%) patients had Migraine without Aura, 36 (9.53%) patients 
had Migraine with Aura, 90(23.09%) patients had Migraine which 
presented with and without aura, 62(17.37%) patients had complications 
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of migraine and 8(2.09%) patients had probable migraine. The ratio of 
Migraine without Aura and Migraine with Aura in our study is calculated 
approximately at 5:1 which correlates with international studies [Allan H 
Ropper 2005].33 however the ratio narrows down to 1.5:1 if migraine 
without aura is compared against migraine with and without aura.  In our 
study of the 382 cases of Migraine, 90 (23.56%) patients had Migraine 
which presented with or without aura. These 90 patients were placed as a 
separate group. This group of patients have has been identified and given 
particular mention in the ICHD 2004 classification. “Many patients who 
have frequent attacks with aura also have attacks without aura (code as 
1.2 Migraine with aura and 1.1 Migraine without aura).” 34 Hence in our 
study we have placed this group of patients as a separate sub entity within 
the entity migraine 
B. Incidence of Tension Type Headaches: In this study of 502 
headache patients 100 (19.92%) had tension type headache, of which 16 
patients had Infrequent Episodic TTH, 24 patients had Frequent Episodic 
TTH, 48 patients had Chronic TTH, and 12 patients had Probable TTH. 
The prevalence of Tension type headache was 40.5% in epidemiological 
studies by Schwartz et al (1998)35. Though tension type headaches are 
considered the most common form of headache in the general population 
with a prevalance of nearly 80% in many studies 31, most of the cases are 
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not reported; many of the patients take self medication, hence the actual 
number of cases seen by physician is less 32. 
 C. Incidence of Trigeminal Autonomic Cephalagias: Out of a 
total of 502 patients registered at the Neurology OPD, 12 (2.39%) had 
Trigeminal autonomic cephalalgia of which 6 patients had Cluster 
Headache, 4 patients had Paroxysmal hemicrania, 2 patients had Short 
Lasting Unilateral Neuralgiform Headache with Conjunctival Injection 
and Tearing. No case of Probable TAC was registered.  
In this study the incidence of cluster headache is 1%, which is in 
contrast to the observation made by Ambar Chakravarthy et al 2004 that 
cluster headache appears to be less common in India than in the west 36. 
The prevalence of cluster headache estimated in U.S is around 0.1%.  
Out of a total of 502 patients registered at the Neurology OPD 8 
(1.59%) had other types of primary headaches of which 2 patients had 
Primary Stabbing Headache, 1 patient had Primary Headache associated 
with Sexual Activity, 1 patient had Primary Hypnic Headache, and 4 
patients had New Daily Persistent Headache 
 
56 
 
II. AGE AND GENDER DISTRIBUTION OF PRIMARY 
HEADACHES 
A. Age Distribution:  
(i) Migraine: Of the 402 patients having migraine most of them 
were between 11-40years of age (11-20yrs - 139 patients, 21-30yrs – 110 
patients, 31-40yrs – 89patients).In this study Migraine with aura peaked 
around 12-17 years of age in males(5 out of 10) and around 18-22 years 
in females(9 out of 26). The onset and peaking in both male and female 
patients in this study is 8-10 years delayed in contrast to that observed  in 
western population  by  Stewart et al [1991]. According to him  the 
incidence of migraine with aura in females peaked between ages 12 and 
13 (14.1/1000 person-years);  and  in males, migraine with aura peaked in 
incidence several years earlier, around 5 years of age at 6.6/1000 person-
years. Before puberty, migraine prevalence is higher in boys than in girls. 
The peak incidence of basilar migraine in this study was around 10-15 
years which correlates with the international literature.  As adolescence 
approaches, incidence and prevalence increase more rapidly in girls than 
in boys. The prevalence increases throughout childhood and early adult 
life until approximately age 40, after which it declines [Stewart WF et al 
1991]37 If the migraine headaches persist beyond 40 years of age there is 
more chance for transformation into chronic migraine.  
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(ii) Tension Type Headache: Of the 100 patients having Tension 
type headache most of them were between 31-50years of age (65 out of 
100 patients, 31-40yrs – 25 patients, 41-50yrs – 40patients). The average 
age of onset of TTH is higher than in migraine in this study, namely 25 to 
30 years. The prevalence peaks between ages 35 to 45 and decreases 
slightly with age. This is in consonance with the observation by 
Rasmussen BK 199538. 
(iii) Trigeminal Autonomic Cephalagias: Of the 12 patients 
having cluster headache most of them (9 out of 12 patients) were between 
31-40years, which correlates with the observation by Bohra et al.200239 
B. Gender Distribution: The patients analysed for gender distribution.   
(i) Migraine:  Of the 382 patients with migraine 68.58% of them 
were females. Female predominance is noted in all groups including 
migraine with aura, migraine without aura, basilar migraine, migraine 
triggered seizures, migrainous infarction and chronic migraine. 
Menstrually related migraine was noticed in 24 patients whereas pure 
menstrual migraine was present in 2 patients. The American Migraine 
Study-1 (AMS-1)[10] and AMS-II, collected information from 15,000 
households representative of the US population in 1989 and 1999. Yet 
another study, the American Migraine Prevention and Prevalence study 
(AMPP) replicated the methods of AMS-I and AMS-II. In these three  
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large studies, the prevalence of migraine was about 18% in women and 
6% in men [Abu-Arefeh.I et al 1994]40  
(ii) Tension Type Headache: In tension headache 68 of the 100 
patients were female; the female-to-male ratio of TTH in this study is 3:1, 
again showing a female preponderance. In western countries the ratio is 
5:4 indicating that, unlike migraine, women are affected only slightly 
more than men [Stovner L,et al 2007]41 
(iii) Trigeminal Autonomic Cephalagias: In cluster headache 10 
of the 12 patients were male In this study male predominance is noted in 
concordance with the observation by Manzoni GC. [Manzoni GC et al 
1998]42 Of the two female patients included under TAC, one had SUNCT 
and other had episodic cluster headache.   .  
C. Family Predilection:  Family history was positive in 229 
patients (45.54%) with migraine. Of the 36 patients with migraine with 
aura 20 out of 36 patients had a first degree relative suffering from 
headache.Russell MB et al [1995] has stated that first degree relatives of 
patients with migraine with aura had a three –four fold   increased risk of 
migraine and it is two fold in first degree relative’s patients with migraine 
with out aura 43.  22 patients (22%) with tension headache in this study 
had a positive family history. Family background of some form of 
headache in 40% of patients with Tension Type Headache has been 
reported by Freidman A et al [1964]44 while Russell MB et al [1999]45 
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reported that parents siblings and children had a 2.1 to 3.9 fold increase 
risk of chronic TTH during their life time. Our study group does not have 
a family history  in the TAC group even though Kudrow L et al.[1980]46 
in his study has reported a high risk of cluster headache by 14 times 
among first degree relatives of cluster headache patients 
III. CLINICAL PRESENTATIONS OF PRIMARY HEADACHES 
A) MIGRAINE:  
1] Location and Character: In patient with migraine 286 
presented with unilateral headache, with 193 of these patients 
experiencing shift of sides while 96 patients had always a unilateral 
headache. The headache was predominantly temporal (217 patients). 
Most of the patients experienced a throbbing type of headache (263 
patients) with a majority of cases (145) lasting for a duration of 12-24 
hours. The predominant premonitory symptom was fatigue (76patients), 
with nausea, , photophobia, phonophobia and blurring of vision the 
commonest associated symptom in order of occurrence.  Loss of 
consciousness was reported in 39 patients.  
2] Aura: Among the several types of aura, visual aura was 
more common (102 of 126 cases) which is in concordance with the 
literature47. Two patients while on treatment for migraine headaches with 
aura, later had only aura alone without headache. The visual aura was 
predominantly in the form of flickering of lights in 70 patients, while zig-
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zag lines, scintillating scotomas and fortification spectra was noted in 17 
patients, 10 patients and 5 patients respectively. This is in correlation 
with most international studies [Christopher J Boes et al 2004]48. When 
patients with typical aura with migraine headache become older, their 
headache may lose migraine characteristics or disappear completely even 
though auras continue47. Sensory aura was reported in 17 patients and 
both in 7 patients. The sensory aura seen was commonly in the form of 
paraesthesia (12 patients).  
3] Aggravating and Relieving Factors: In our study the 
most common aggravating factors were mental stress, while physical 
stress and lack of sleep were also commonly reported. Head bath as an 
aggravating factor has been observed in 116 patients. A similar 
observation has been referred to by Ravishankar et al 200618. This 
prospective study analysed this unusual trigger link in 94 out of 1000 
Indian patients who fulfilled the International Headache Society criteria 
for migraine. In 11 patients, hair wash was the only trigger; in 45 patients 
hair wash was one of the triggers and in 38 patients hair wash was a 
trigger concurrently and in combination with another common trigger. 
The effect of episodic and long-term prophylaxis in preventing this 
trigger-like headache has been analysed. The relieving factors were 
mostly rest and analgesic ingestion and sleep.  
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4] Associated Clinical Conditions: In our study of 402 
patients with migraine the following clinical conditions were seen 
associated – namely evidence of healed Granuloma, Seizures, 
Hypertension and Stroke. The risk of stroke may be increased two to 
threefold in migraine sufferers. Young adult sufferers and women 
using hormonal contraception appear to be at particular risk. The 
mechanism of this association though vastly unclear is attributed to 
chronic abnormalities of cerebral blood vessel tone [Etminan M et al 
2005]49. Women who experience auras have been found to have twice the 
risk of strokes and heart attacks over non-aura migraine sufferers and 
women who do not have migraines [Kurth T et al 2006]43. Similar 
observation was made in this study and all the patients who had 
migrainous strokes were female and all of them had migraine with 
aura. Migraine sufferers seem to be at risk for both thrombotic and 
hemorrhagic stroke as well as transient ischemic attacks [Becker C et al 
2007] 51  
Ten patients had basilar migraine and 7 out of 10 patients 
were in 1st and 2nd decade. The symptoms experienced by majority of 
them were vertigo, diplopia, ataxia, parasthesias, hemianopias, and 
decreased level of consciousness. These observations are in correlation 
with most international studies. Basilar migraine is common is adolescent 
age groups.  With increasing maturity of the nervous system attacks of 
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basilar migraine become less common and generally are replaced by 
migraine without aura [Peatfield RC et al 2000]52. 
5] Complication of Migraine:  
(i) Chronic Migraine: In our study of the 382 case of 
Migraine, 62(16-18%) patients had complications of migraine. Of these 
62 patients, 48 patients had Chronic Migraine (12 patients of Chronic 
Migraine since Onset & 36 patients of Episodic Headache converting to 
Migraine), 1 patient had Migrainous Infarction (Right Occipital Infarction 
-1) and 13 patients had Migraine Trigerred Seizures (Migraine 
Terminating as Seizures – 9, Migralepsy - 4). In our study, the most 
common complication observed in patients with migraine was 
transformation of migraine to chronic migraine or chronic daily headache. 
As the chronicity develops migraine headache lost its episodic 
presentation. Most of these patients with transformed migraine are 
patients with migraine without aura which is concordant with the studies 
of Siberstein SD et al 200153.  One patient was diagnosed to have 
migrainous infarction in our study. She was a female of age of 28 years. 
Women who experience auras have been found to have twice the risk of 
strokes and heart attacks over non-aura migraine sufferers and women 
who do not have migraines [Kurth T et al 2006]50, 54. 
 (ii) Migraine Trigerred Seizures: In our study, we came 
across 52 instances of Migraine associated with Seizures, 13 patients had 
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Migraine Triggered Seizures, 17 patients had Post Ictal Migrainous 
Headache and 22 patients had Migraine & Coexistent Seizure. Of the 13 
patients who had Migraine Triggered Seizures, 9 patients had Migraine 
Terminating as Seizures and 4 patients had Migralepsy. Analysis of the 
13 patients showed that 7 patients had GTCS, 6 patients had CPS. 
Migralepsy as defined in literature are seizures occurring during or within 
an hour of migrainous aura [Lennox WG et al 1960]55. In our study of 
these 13 patients who had migraine which terminated as seizures, 9 
patients differed from the classical description of migralepsy in their 
duration of headache with a window period of more than two to three 
hours well outside the defined window period of 1 hour. This group of 9 
patients presented with both migraine with aura and migraine without 
aura. All of these 9 patients responded to anti-migrainous prophylaxis 
alone with a 1year episode free period. Hence these patients were 
grouped as Migraine triggered seizures. These observations in our study 
correlate with observations of Anderman F et al (1987)56. Marks and 
Ehernberg et al [1993]57 evaluated and established the relationship 
between catamenial epilepsy and patients with migraine with aura, 
showing an increased risk for an association between seizures and 
migraine. Lenaerts et al [1999]58evaluated the degree of co-morbidity and 
established the pattern of temporal relationship between migraine and 
epilepsy in 202 patients in tertiary care clinics, which outlines that 
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Migraine attacks equally precede or follow seizures, but migraine aura 
more often preceded the seizure. In analyzing our group of patients, 
migraine preceeded the seizures in 13 of 52 patients. Of the 13 patients, 4 
patients had migralepsy and 9 patients had migraine which terminated as 
seizures. Relationship between duration of headache and terminations as 
seizures was analysed. In our patients, all had a prolonged duration of 
migraine ranging from 2 to >12hrs duration preceding seizures. This 
observation in our study is in contrast to the observation of Young et al 
[1983]59 in their epilepsy unit, where their patients had a brief duration of 
headache lasting for upto 20 minutes.Headache can also be the sole or 
most predominant manifestation of epileptic seizures, though this is a 
relatively rare situation [Laplante P et al 1983]60 
B. TENSION TYPE HEADACHE In patients with TTH 56 presented 
with headache of more than 12hours duration, while 25 patients had 
duration of 6-12 hours and 19 patients had a duration of 1-6hours. 62 of 
these patients experienced bilateral headaches and in most confined to the 
frontal region. Bendtsen L et al [2006]61 evaluated and compiled the 
features of tension type headache. TTH is characterized by a bilateral, 
pressing, tightening pain of mild to moderate intensity, occurring in short 
episodes of variable duration (episodic forms) or continuously (chronic 
form). The headache is not associated with the typical migraine features, 
such as vomiting, severe photophobia, and phonophobia. In the chronic 
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form, only one of these accompanying symptoms is allowed and only 
mild nausea is accepted. Because of lack of accompanying symptoms and 
milder pain intensity, patients rarely are severely incapacitated by their 
pain. TTH is the most featureless of the primary headaches and, because 
many secondary headaches may mimic TTH, a diagnosis of TTH requires 
exclusion of other organic disorders. A general and neurologic 
examination and prospective follow-up using headache diaries with 
registration of all consumed drugs are, therefore of utmost importance to 
reach a diagnosis. There are no reliable specific paraclinical tests that are 
useful in differential diagnosis. Manual palpation of the pericranial 
muscles and their insertions should be done to demonstrate a possible 
muscular factor for patients and to plan treatment strategy, where 
physical training and relaxation therapy are important components. 
[Jensen R 1999]62 
Most of the patients experienced aching type of headache (60 
patients), while it was band like in 30 patients and throbbing in 7 patients. 
The predominant premonitary symptom was irritability (19 patients) with 
photophobia, phonophobia, nausea were other common associated 
symptoms in order of occurrence.  The most common aggravating factor 
in our study group was mental stress, while physical stress, travel, head 
bath and lack of sleep were also commonly reported. The relieving 
factors were mostly pressure and analgesics and coffee / tea ingestion. As 
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TTH was commonly associated with depression and is aggravated by 
mental stress, previously was thought to be psychogenic now a 
neurological basis was established. Other common aggravating factors 
include poor self related health, inability to relax after work and sleeping 
few hours per night (Bendsten L etal 2000)63. In our study of 100 patients 
with TTH the following clinical conditions were seen associated – 
namely evidence of healed Granuloma, Hypertension.  
C. CLUSTER HEADACHE & OTHER TRIGEMINAL 
AUTONOMIC CEPHALAGIAS 
In patients with TAC, 10 presented with headache of less than 6 
hours duration, while 2 patients had duration of 6-12 hours. One of the 
patients experienced bilateral headaches while 11 had unilateral 
headaches with most (10 patients) confined to the frontal temporal region. 
Most of the patients experienced an aching type of headache (11 patients), 
while it was pricking in 1 patient. The predominant premonitary symptom 
was nausea and vomiting and redness of eyes with nasal stuffiness (11 
patients), phonophobia, photophobia, drooping of eyelids and blurring of 
vision being the other common associated symptoms in order of 
occurrence.  Aggravating factors that were reported in most patients in 
our study were alcohol intake, sunlight and lack of sleep. The relieving 
factors were mostly analgesics, pressure and coffee / tea ingestion. Our 
observations are in consonance with Rozen TD et al [1999]64 describing 
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the features of typical cluster headache. Typical cluster headache location 
is retro-orbital, periorbital, and occipitonuchal. Maximum pain is 
normally retro-orbital in more than 70% of patients. Pain quality is 
described as boring, stabbing, burning, or squeezing. Cluster headache 
intensity is always severe and never mild, although headache pain 
intensity may be less at the beginning and end of cluster periods. The 
duration of individual cluster headaches is between 15 minutes and 180 
minutes, with more than 75% attacks lasting less than 60 minutes. Attack 
frequency is between one and three attacks per day, with most patients 
experiencing two or fewer headaches in a day. Cluster headache is 
marked by its associated autonomic symptoms that typically occur on the 
same side as the head pain but can be bilateral. Lacrimation is the most 
common associated symptom, occurring in 73% of patients, followed by 
conjunctival injection in 60%, nasal congestion in 42%, rhinorrhea in 
22%, and a partial Horner’s syndrome in 16% to 84%.  
 
IV DIAGNOSTIC STUDIES 
A. Electrophysiology:  
(i) Migraine: EEG was taken in 52 of the 382 patients with 
migraine. 33 of the 52 patients showed non specific slowing in Posterior 
Region, while 5 patients showed Spikes & Sharp Waves in Occipital 
Region while 14 of the patients had no specific changes. The EEG 
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features in our patients were sharp waves and spikes in posterior occipital 
region mainly occipital region (5 patients of migraine triggered seizures), 
more during the period of aura and was normal during the interval period 
between attacks of migraine. This correlates with a large multicenter 
study - incidence of spikes and paroxysmal events was 12.5% compared 
to 0.7% in normal adult volunteers. The percentage goes still high up in 
patients with seizures. Monomorphic or polymorphic slow waves, seen 
bilaterally. Few cases also showed slowing in posterior head region 
[Beaumanoir A et al 1987]65.  
(ii) TTH: EEG was taken in 9 of the 100 patients with TTH, 3 of 
these patients showed non specific slowing in Posterior Region, while 6 
of the patients had no specific changes. 
(iii) TAC: EEG was taken in 2 of the 12 patients with Cluster 
Headache, these 2 patients showed no specific changes.  
B. Radio-Imaging Studies: (i) Migraine: CT scan of brain was 
taken in all of the 382 patients, of whom 40 had changes. The most 
common change reported in CT scan brain was calcified granulomas in 
36 patients, gliosis in 3 patients and basal ganglia calcification in 1 
patient. Frishberg BM et al  199466 reviewed four CT scan studies, four 
MRI scan studies, and one combined MRI and CT scan study of 897 
scans of patients who had migraine. These findings are combined with 
more recent reports of one CT scan study of 284 patients and six studies 
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of MRI scans of 444 patients for a total of 1625 scans of patients who had 
various types of migraine. Other than white matter abnormalities, the 
studies showed no significant pathology except for four brain tumours 
(three of which were incidental findings) and one AVM (in a patient who 
had migraine and a seizure disorder).  
V. PROPHYLAXIS 
A. Migraine: The patients with migraine were given prophylactic 
therapy with either Propronolol (20-160mg) or Amitryptyline (12.5-50mg) 
or Propronolol (20-160mg) and Amitryptyline (12.5-50mg) or Sodium 
Valproate ER(15 to 20mg/kg). Patients with all types of migraine 
responded well to prophylactic therapy with headache free interval of 
more than six months in majority. Among 218 patients with migraine 
who were on combination prophylaxis with Amitryptiline and 
Propronolol 35 (16%) responded with disease free period of more than 1 
year and a further 71(33%) responded with disease free period of more 
than 6 months, 62(28%) patients responded with disease free period of 
less than 6 months while the remaining 50(23%) responded with 
decreased intensity and frequency of pain. Among 122 patients who were 
on Propronolol alone 15 (12%) responded with disease free period of 
more than 1 year, 33(27%) responded with disease free period of more 
than 6 months, 31(26%) patients responded with disease free period of 
less than 6 months while the remaining 43(35%) responded with 
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decreased intensity and frequency of pain. Among the 39 patients on 
Amitryptiline 4 (10%) responded with disease free period of more than 1 
year, 7(18%) responded with disease free period of more than 6 months,9 
(23%) patients responded with disease free period of less than 6 months, 
14(36%) responded with decreased intensity and frequency of pain and 
the remaining 5 (13%) showed no response. Among the 3 patients treated 
with sodium valproate 2(67%) responded with disease free period of 
more than 6 months and 1(33%) patient responded with decreased 
intensity and frequency of pain. 
        This is in correlation with meta analysis from many studies which  
showed  that beta  blockers were associated with reduction in migraine  
activity and more   than 100 clinical trials clearly established the benefits  
of propronolol [Linde K et all] 67. In a systematic review of 26 clinical 
trials, propranolol  was shown to be more  effective than placebo in  
reducing   migraine  frequency among   adults.  Disease free interwal of 1 
year period for  patients on migraine  prophylaxis varied from 8 to 22%  
[Linde et all 2004].67  Propronolol significantly reduced the headache 
index(a composite score  that takes into account both intensity and 
duration) in 56% of  patients68 [Modi S et all] In a double-blind  
controlled clinical  trial Amitriptyline reduced both intensity and duration 
of migraine  attacks in 44% of cases[ Gomersall and Stuart]69. In a 
double-blind study of   sodium valproate  versus placebo Hering R et all70  
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found effectiveness of   valproate   in reducing severity and frequency of 
migraine attacks in   86.2% of patients. 
  
B. Tension Type Headaches: All patients in our study were 
treated with Amitryptiline (10-50mgms). Of the 100 patients 6 patients 
responded with a disease free interval of 1year, 17 patients with a disease 
free interval of 6 months to 1 year, 35 patients with a disease free interval 
of less than 6months, 34 patients responded with decreased intensity and 
frequency of episodes while 8 patients did not show any response. This is 
in concordance with various studies. Prophylactic pharmacotherapy 
include tricyclic antidepressant, amitriptyline is the only drug proved 
effective in several controlled trials in TTH. [Bendtsen L et al 2005]71. 
The two most recent studies reported that amitriptyline (75 mg per day) 
reduced headache duration and intensity by 30% compared with placebo. 
The effect is long lasting (at least 6 months) and not related to the 
presence of depression. [Bendtsen L et al 1996]72. If patients do not 
respond to amitriptyline, mirtazapine could be attempted. Venlafaxine or 
SSRIs could be considered in patients who have concomitant depression, 
if tricyclics or mirtazapine are not tolerated.  
C. Trigeminal Autonomic Cephalalgia: One patient with 
SUNCT responded to prophylaxis with sodium valproate with decreased 
disease intensity and frequency. Five patients with paroxysmal 
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hemicrania responded well to Indomethacin during acute phases and were 
given prophylaxis with Amitrptiline with good response. Three patients 
had a disease free interval of less than six months and two patients had 
decreased disease intensity and frequency. Prophylaxis was provided for 
6 patients with cluster headache of which 4 were given Amitryptiline  
(25-50mgms), 2 patients were given Propranolol (80-120mgms). Of the 4 
patients given Amitryptiline 3 patients responded with decreased disease 
intensity and frequency, 1 patient with a disease free interval of 6 months 
to 1 year. Of the 2 patients given Propranolol, both of them responded 
with a disease free interval of 1year. These drug responses are at variance 
to usual observations, these patients showing marked responses indicating 
that these were probable Cluster Headache Migraine overlap syndromes. 
Solomon S et al [1986]73 has referred to a similar clinical situation were 
the patients had clinical features of both types of headaches. Graham et al 
[1975]74 described combined syndromes and has described migraine 
headaches in recurrent bouts resembling cluster headache responding to 
migraine prophylaxis.    
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CONCLUSIONS 
The observations of this study are here with summarised  
 
1. Migraine is the commonest type of headache comprising of about 
76%. Migraine without aura [48%] was more common than 
migraine with aura [32%]. Female preponderance was noticed in 
all subtypes of migraine, age of onset being in 2nd and 3rd decade 
for majority of the subgroups of migraine, except for basilar 
migraine which was common in 1st and 2nd decade. Migraine pain 
was temporal in location, unilateral, throbbing in character, lasting 
for 12 to 24 hours in majority of the cases. 
2.  Chronic migraine, Migraine triggered seizures and Migrainous 
infarction were the complications of migraine encountered in this 
study in the order of frequency of occurrence. Transformation to 
Chronic migraine was more common from episodic forms and in 
patients with onset of migraine in teens or twenties. Among 
patients with migraine and seizures, 13 patients were grouped 
under migraine triggered seizures that differed from the classical 
description of migralepsy in their duration of headache, with a 
window period of more than two hours prior to the seizure. This 
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group of patients presented with both migraine with aura and 
migraine without aura and responded to anti-migrainous 
prophylaxis alone with a 1 year episode free period. 
3. Tension type headache constituted about 20% of cases, Chronic 
tension type headache was the commonest type (48%), majority of 
cases occurred in fourth decade with female preponderance. 
4. Patients with all types of migraine responded well to Antimigraine 
prophylactic drugs. Among migraine patients on combination 
prophylaxis with Propronolol and amitryptiline, 16% responded 
with disease free interwal of more than 1 year, while it was 12% 
for patients on propronolol and 10% for patients on amitryptiline. 
The response rate with disease free interwal in the range of 6 to 12 
months was 33%, 27% and 18% for the above respective group of 
drugs. 
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APPENDIX-1                                         
 
PROFORMA  FOR  HEADACHE 
 
 
Name:                                                    Age:                                                      Sex: 
 
Residential address: 
 
 
Occupation: 
 
NM No:                                                                         
 
Details about headache:     How long-  
  
                                            Age of onset- 
 
                                            Headache free period if any- 
 
Duration in hours- 
 
Location-   Unilateral-                         Bilateral- 
 
Temporal-                    Frontal -                   Occipital -                   Holocranial- 
 
 
Radiation  to neck-                        Retro orbital region-            Limbs ( UL & LL) – 
 
 
Character-   Throbbing-                    Tight sensation-                  Shock like- 
 
 
                     Pricking-                        Aching-  
 
                               
Frequency-     Episodes/week-                  Episodes/month- 
 
Recent change in frequency- 
 
Frequency with prophylactic drugs- 
 
 
 
Associated features-    Photophobia and phonophobia- 
 
                                     Nausea and vomiting- 
 
                                      Drowsiness- 
 
                                     Giddiness/ vertigo- 
 
                                      LOC- 
 
                                      Redness of eyes- 
 
                                      Lacrimation-  
             
                                      Diplopia-  
 
                                          Parasthesias- 
 
 
Aura-  Visual-  phenomena: 
 
 
 Positive visual phenomena:                               Small bright dots- 
 
                                                                          White spots/ flashes of light (photopsias)- 
 
                                                                            Fortification spectra (teichopsia)- 
 
                                                                             Other zig zag lines- 
 
                                                                               Coloured spots of light- 
                                                                                 
  Negative visual phenomena:                               Blind spots (scotomas)- 
 
                                                                            Black dots/ spots- 
 
                                                                            Hemianopias- 
 
 
  Disturbances of visual perception-                        blurred vision- 
 
                                                                                     Micropsia/ macropsia/teleopsia- 
 
                                                                                      Tunnel vision- 
 
 
Triggering factors-       Physical stress/ mental stress-  
 
                                    Sunlight- 
 
                                      Sleep alteration- 
 
                                           Travel- 
 
                                       Headbath- 
                                                        
                                           Perfumes/fumes- 
 
 
                                        Cold items- 
                                                        
                                           Position of neck- 
 
                                         Others- 
 
 
Relieving factors-          Pressure- 
                                                          
                                            Coffee/ tea- 
 
                                        Analgesics 
                                                        
                                            Rest-. 
 
 
 
Relationship to menstrual cycles- 
  
Family history- 
 
 
 
On Examination-      BP-   
                                   
                                            Temporal artery-                       
                                              
                                             Sinuses- 
                                  
                                  Palpabrel fissure-               
 
                                            Refraction-                              
 
                                            Fundii- 
 
                                   Cranial nerves- 
 
                                     Long tract signs- 
 
 
 
Associated conditions-    Seizures-   
 
                                            HT-                         
 
                                            Stroke- 
                              
                                           Granulomatous diseases- 
 
                                            Psychiatric diseases- 
 
Investigation-        CT scan Brain- 
 
 
                              EEG- 
 
 
                                           MRI Brain- 
 
 
 
Diagnosis-              Primary/ Secondary- 
 
                                Migraine  /  Tension type headache  /  Short lasting headache  /   
            
                                 Cluster headache  /  Paroxysmal hemicranias 
 
 
Medications-            Propranolol  
 
                                           Sodium valproate 
 
                                  Amitryptyline  
 
                                            Flunarizine 
 
                                            Paracetamol 
 
                                            Other NSAIDs 
 
Follow up- 
 
1 35 F 18 Temporal Throbbing 6 Visual MWA prop DFI-12M MWA – Migraine with Aura
2 36 F 6 TEMPORAL ACHE 4 PTTH Amitryptiline DIF MWOA – Migraine without Aura
3 31 F 14 Temporal Throbbing 20 CM amt + prop DIF MWWOA - Migraine with and without Aura
4 38 F 20 OCCIPITAL PRICKING 3 IETTH Amitryptiline DFI-6M CM-   Complications of Migraine
5 17 M 15 Temporal Pricking 4 Sensory & Visual MWA prop DIF PM-  Probable Migraine
6 33 F 30 Temporal Throbbing 3 MWOA prop DIF TTH-Tension type Head ache
7 43 F 7 OCCIPITAL ACHE 11 FETTH Amitryptiline DIF
FETTH-Frequent Episodic Tension type Head 
ache
8 39 M 10 Frontotemp Aching 15 CCH propronolol DFI-12M
IETTH-Infrequent Episodic Tension type head 
ache
9 8 F 18 Occipital Aching 12 MWOA prop DFI-6M PTTH- Probable Tension type Head ache
10 50 F 24 Frontal Throbbing 16 CM amt + prop DIF CTTH-Chronic Tension type head ache
11 37 M 18 Temporal Throbbing 6 Sensory MWWOA amt + prop DIF TAC- Trigeminal Autonomic Cephalagias
12 32 M 14 Temporal Burning 5 MWOA prop DIF CCH – Chronic Cluster Headache
13 18 F 18 Parietal Throbbing 8 MWOA prop DIF ECH –Episodic Cluster Headache
14 15 M 18 Temporal Pricking 2 MWOA prop DIF EPHC – Eposodic Paroxysmal Hemicrania
15 32 F 12 Frontal Throbbing 12 PM amt + prop DIF CPHC – Chronic Paroxysmal Hemicrania
16 15 F 24 Frontal Throbbing 15 CM amt + prop DIF DFI-12m- Disease free interval  for 12 months
17 29 M 3 OCCIPITAL ACHE 20 CTTH Amitryptiline DFI-6M
DFI-6m+ - Disease free interval 6months -12 
months
18 32 F 9 Parietal Diffuse 6 MWOA amt + prop DIF
DFI-6m - Disease free interval less than 6 
months
19 44 F 14 Frontal Throbbing 20 CM amt + prop DIF NR – No response
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20 33 M 20 Temporal Throbbing 8 Visual MWWOA amt + prop DIF MWA – Migraine with Aura
21 35 F 12 Parietal Throbbing 6 Visual MWA prop DIF MWOA – Migraine without Aura
22 36 M 15 Temporal Throbbing 6 PM amt + prop DIF MWWOA - Migraine with and without Aura
23 17 F 24 OCCIPITAL ACHE 7 FETTH Amitryptiline DIF CM-   Complications of Migraine
24 14 F 18 Temporal Aching 4 MWOA prop DIF PM-  Probable Migraine
25 38 F 15 Temporal Aching 2 Sensory MWWOA amt + prop DIF TTH-Tension type Head ache
26 10 F 18 Temporal Throbbing 6 MWOA prop DFI-12M
FETTH-Frequent Episodic Tension type Head 
ache
27 42 F 22 OCCIPITAL ACHE 15 CTTH Amitryptiline DIF
IETTH-Infrequent Episodic Tension type head 
ache
28 42 F 12 Frontal Throbbing 18 CM amt + prop DFI-6M+ PTTH- Probable Tension type Head ache
29 33 F 14 Temporal Throbbing 8 Visual MWWOA amt + prop DIF CTTH-Chronic Tension type head ache
30 38 M 18 Temporal Pricking 2 MWOA prop DIF TAC- Trigeminal Autonomic Cephalagias
31 16 F 3 TEMPORAL THROBBING 4 IETTH Amitryptiline DFI-6M+ CCH – Chronic Cluster Headache
32 33 M 6 Frontotemp Aching 24 ECH Amitryptiline DFI-6M+ ECH –Episodic Cluster Headache
33 33 M 8 Temporal Pricking 4 MWOA prop DFI-6M EPHC – Eposodic Paroxysmal Hemicrania
34 31 M 24 Temporal Throbbing 6 Visual MWWOA amt + prop DFI-6M+ CPHC – Chronic Paroxysmal Hemicrania
35 28 F 24 OCCIPITAL ACHE 5 PTTH Amitryptiline DIF DFI-12m- Disease free interval  for 12 months
36 15 F 12 Temporal Aching 6 MWOA prop DIF
DFI-6m+ - Disease free interval 6months -12 
months
37 32 F 18 Frontal Throbbing 2 Visual MWWOA amt + prop DIF
DFI-6m - Disease free interval less than 6 
months
38 29 F 3 OCCIPITAL BAND 3 IETTH Amitryptiline DIF NR – No response
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39 40 F 18 Frontal Pricking 3 MWOA prop DIF MWA – Migraine with Aura
40 32 F 24 Temporal Throbbing 4 Visual MWA prop DFI-12M MWOA – Migraine without Aura
41 38 F 18 TEMPORAL ACHE 20 CTTH Amitryptiline DFI-6M+ MWWOA - Migraine with and without Aura
42 35 F 18 Parietal Throbbing 5 MWOA prop DIF CM-   Complications of Migraine
43 48 M 16 FRONTAL PRICKING 10 FETTH Amitryptiline DFI-6M PM-  Probable Migraine
44 20 F 18 Temporal Throbbing 8 Visual MWA amt + prop DFI-6M+ TTH-Tension type Head ache
45 37 M 24 Temporal Pricking 10 MWOA amt + prop DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
46 31 F 30 Frontal Aching 12 MWOA amt + prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
47 32 F 7 Frontal Throbbing 4 Visual MWA prop DFI-12M PTTH- Probable Tension type Head ache
48 42 F 14 Temporal Throbbing 2 MWOA prop DIF CTTH-Chronic Tension type head ache
49 45 F 15 Temporal Aching 2 Sensory MWWOA amt + prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
50 17 M 24 Temporal Pricking 3 Visual MWWOA prop DIF CCH – Chronic Cluster Headache
51 36 F 15 Frontal Throbbing 22 CM amt + prop DFI-6M+ ECH –Episodic Cluster Headache
52 14 F 9 Temporal Pricking 4 sensory MWWOA amt + prop DFI-6M+ EPHC – Eposodic Paroxysmal Hemicrania
53 47 M 24 Temporal Diffuse 8 MWOA prop DIF CPHC – Chronic Paroxysmal Hemicrania
54 35 F 14 Temporal Throbbing 5 MWOA prop DIF DFI-12m- Disease free interval  for 12 months
55 12 M 18 Temporal Throbbing 4 Sensory & Visual MWA prop DIF
DFI-6m+ - Disease free interval 6months -12 
months
56 18 M 24 Frontal Diffuse 11 MWOA prop DIF
DFI-6m - Disease free interval less than 6 
months
57 36 F 15 Temporal Throbbing 12 MWOA prop DIF NR – No response
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58 13 M 18 Occipital Throbbing 3 Visual MWA prop DFI-12M MWA – Migraine with Aura
59 49 F 18 Temporal Throbbing 6 Visual gliosis Stroke MWA amt + prop DFI-6M+ MWOA – Migraine without Aura
60 14 M 14 Frontal Throbbing 7 MWOA amt + prop DIF MWWOA - Migraine with and without Aura
61 12 M 18 Temporal Throbbing 2 sensory MWWOA amt + prop DFI-6M+ CM-   Complications of Migraine
62 48 M 16 FRONTAL ACHE 10 FETTH Amitryptiline DFI-6M PM-  Probable Migraine
63 15 F 24 Frontal Throbbing 20 CM amt + prop DFI-12M TTH-Tension type Head ache
64 16 F 18 Parietal Pricking 5 MWOA prop DFI-6M
FETTH-Frequent Episodic Tension type Head 
ache
65 40 F 12 Temporal Throbbing 19 CM amt + prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
66 38 M 24 FRONTAL BAND 7 FETTH Amitryptiline DIF PTTH- Probable Tension type Head ache
67 25 F 15 Temporal Aching 7 MWOA prop DFI-6M+ CTTH-Chronic Tension type head ache
68 18 M 13 Frontal Throbbing 5 Visual MWWOA amt + prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
69 36 F 5MIN Frontotemp Aching 30 ECH Amitryptiline DIF CCH – Chronic Cluster Headache
70 22 M 24 Frontal Throbbing 4 MWOA prop DFI-6M+ ECH –Episodic Cluster Headache
71 38 F 18 Temporal Aching 10 MWOA prop DIF EPHC – Eposodic Paroxysmal Hemicrania
72 19 F 18 TEMPORAL ACHE 20 CTTH Amitryptiline DFI-6M+ CPHC – Chronic Paroxysmal Hemicrania
73 12 M 14 Frontal Throbbing 8 MWOA prop DIF DFI-12m- Disease free interval  for 12 months
74 40 F 24 Temporal Throbbing 3 Visual MWWOA amt + prop DFI-6M+
DFI-6m+ - Disease free interval 6months -12 
months
75 34 M 4 TEMPORAL ACHE 16 CTTH Amitryptiline DFI-12M
DFI-6m - Disease free interval less than 6 
months
76 24 F 18 Temporal Pricking 4 MWOA amt + prop DIF NR – No response
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77 18 F 14 Frontal Throbbing 2 Visual MWA prop DFI-6M+ MWA – Migraine with Aura
78 17 F 4 FRONTAL THROBBING 17 CTTH Amitryptiline DFI-6M MWOA – Migraine without Aura
79 45 F 24 Temporal Throbbing 19 CM amt + prop DFI-6M+ MWWOA - Migraine with and without Aura
80 35 F 24 FRONTAL BAND 7 FETTH Amitryptiline DIF CM-   Complications of Migraine
81 16 F 18 Parietal Aching 5 MWOA prop DIF PM-  Probable Migraine
82 15 F 18 Temporal Throbbing 8 Visual MWWOA amt + prop DFI-6M+ TTH-Tension type Head ache
83 28 F 14 Temporal Throbbing 11 MWOA prop DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
84 36 F 14 OCCIPITAL ACHE 3 PTTH Amitryptiline DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
85 14 M 7 Frontal Aching 2 LOC MWOA amt + prop DIF PTTH- Probable Tension type Head ache
86 22 F 15 FRONTAL ACHE 12 IETTH Amitryptiline DIF CTTH-Chronic Tension type head ache
87 38 M 24 Temporal Aching 20 CM amt + prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
88 53 F 18 Temporal Throbbing 18 CM amt + prop DIF CCH – Chronic Cluster Headache
89 36 F 6 FRONTAL ACHE 4 YES PTTH Amitryptiline DIF ECH –Episodic Cluster Headache
90 26 M 18 Frontal Throbbing 3 MWOA Amit NR EPHC – Eposodic Paroxysmal Hemicrania
91 45 M 36 FRONTAL ACHE 2 Gliosis IETTH Amitryptiline DFI-6M CPHC – Chronic Paroxysmal Hemicrania
92 24 F 18 Frontal Throbbing 8 MWOA prop DFI-6M+ DFI-12m- Disease free interval  for 12 months
93 32 F 24 Temporal Pricking 2 MWOA Amit DIF
DFI-6m+ - Disease free interval 6months -12 
months
94 36 F 15 Frontal Throbbing 22 CM amt + prop DFI-6M+
DFI-6m - Disease free interval less than 6 
months
95 49 F 9 FRONTAL THROBBING 17 CTTH Amitryptiline DFI-6M NR – No response
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96 42 F 9 FRONTAL THROBBING 17 CTTH Amitryptiline DFI-6M MWA – Migraine with Aura
97 39 M 6 Frontotemp Aching 30 CCH propronolol DFI-12M MWOA – Migraine without Aura
98 18 F 14 Temporal Throbbing 4 Visual MWA prop DFI-6M+ MWWOA - Migraine with and without Aura
99 29 F 8 OCCIPITAL BAND 3 IETTH Amitryptiline DIF CM-   Complications of Migraine
100 36 M 24 Temporal Throbbing 15 CM amt + prop DFI-6M+ PM-  Probable Migraine
101 14 M 24 Temporal Throbbing 3 MWOA prop DFI-6M TTH-Tension type Head ache
102 17 F 4 Parietal Burning 5 MWOA amt + prop DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
103 18 F 16 Frontal Throbbing 4 MWOA prop DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
104 18 M 13 Frontal Throbbing 5 Visual MWWOA amt + prop DFI-6M+ PTTH- Probable Tension type Head ache
105 9 M 4 Occipital Aching 2 Visual MWA prop DFI-6M CTTH-Chronic Tension type head ache
106 43 F 7 FRONTAL BAND 11 calcific granuloma FETTH Amitryptiline DIF TAC- Trigeminal Autonomic Cephalagias
107 42 F 14 Temporal Throbbing 20 CM amt + prop DFI-6M+ CCH – Chronic Cluster Headache
108 26 F 12 Temporal Throbbing 2 Visual MWA prop DFI-6M ECH –Episodic Cluster Headache
109 34 M 24 Temporal Pricking 4 MWOA Amit DIF EPHC – Eposodic Paroxysmal Hemicrania
110 43 F 9 FRONTAL THROBBING 17 CTTH Amitryptiline DFI-6M CPHC – Chronic Paroxysmal Hemicrania
111 24 F 18 Frontal Throbbing 8 MWOA prop DFI-6M+ DFI-12m- Disease free interval  for 12 months
112 22 M 15 Temporal Throbbing 6 PM amt + prop DIF
DFI-6m+ - Disease free interval 6months -12 
months
113 32 F 12 Temporal Throbbing 5 MWOA prop DFI-6M+
DFI-6m - Disease free interval less than 6 
months
114 47 F 9 FRONTAL THROBBING 17 CTTH Amitryptiline DFI-6M NR – No response
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115 14 F 18 Occipital Aching 3 Visual MWWOA prop DFI-12M MWA – Migraine with Aura
116 34 M 8 Frontotemp Aching 60 EEH Amitryptiline DIF MWOA – Migraine without Aura
117 45 F 24 Temporal Throbbing 20 CM amt + prop DFI-6M+ MWWOA - Migraine with and without Aura
118 28 M 18 Temporal Pricking 8 Visual MWWOA amt + prop DIF CM-   Complications of Migraine
119 24 M 12 Frontal Throbbing 6 MWOA amt + prop DFI-6M+ PM-  Probable Migraine
120 26 F 24 Temporal Throbbing 4 Visual MWWOA prop DIF TTH-Tension type Head ache
121 15 F 18 Temporal Throbbing 2 MWOA prop DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
122 13 F 18 Occipital Throbbing 5 Visual MWWOA amt + prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
123 45 F 36 TEMPORAL BAND 9 IETTH Amitryptiline NR PTTH- Probable Tension type Head ache
124 49 M 6 Frontotemp Aching 30 EEH Amitryptiline DIF CTTH-Chronic Tension type head ache
125 53 F 24 Temporal Diffuse 18 CM amt + prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
126 18 F 14 Temporal Throbbing 3 MWOA amt + prop DFI-6M+ CCH – Chronic Cluster Headache
127 38 M 12 Frontal Throbbing 5 MWOA Amit DFI-6M ECH –Episodic Cluster Headache
128 22 F 18 Temporal Throbbing 2 Visual MWA prop DFI-6M+ EPHC – Eposodic Paroxysmal Hemicrania
129 20 F 18 Occipital Aching 1 MWOA prop DFI-12M CPHC – Chronic Paroxysmal Hemicrania
130 48 F 5 FRONTAL THROBBING 17 CTTH Amitryptiline DFI-6M DFI-12m- Disease free interval  for 12 months
131 28 M 6 Temporal Throbbing 8 MWOA amt + prop DIF
DFI-6m+ - Disease free interval 6months -12 
months
132 22 M 15 Temporal Throbbing 6 PM amt + prop DFI-6M
DFI-6m - Disease free interval less than 6 
months
133 36 F 18 Temporal Throbbing 20 CM amt + prop DFI-6M+ NR – No response
ABBREVIATIONS
F
A
M
I
L
Y
 
H
I
S
T
O
R
Y
C
T
S
C
A
N
 
-
 
B
R
A
I
N
C
O
M
P
L
I
C
A
T
I
O
N
S
D
I
A
G
N
O
S
I
S
F
R
E
Q
U
E
N
C
Y
 
/
 
M
O
N
T
H
A
U
R
A
P
R
O
P
H
Y
L
A
X
R
E
S
P
O
N
S
E
L
O
C
A
T
I
O
N
C
H
A
R
A
C
T
E
R
N
O
A
G
E
S
E
X
D
U
R
A
T
I
O
N
 
I
N
 
H
R
S
134 34 M 18 Frontal Throbbing 7 Visual MWWOA Amit DFI-6M+ MWA – Migraine with Aura
135 45 M 24 FRONTAL ACHE 2 Gliosis IETTH Amitryptiline DFI-6M MWOA – Migraine without Aura
136 16 F 14 Frontal Throbbing 4 MWOA prop DFI-6M+ MWWOA - Migraine with and without Aura
137 18 F 24 Temporal Pricking 8 Visual MWWOA amt + prop DFI-6M CM-   Complications of Migraine
138 45 F 36 TEMPORAL BAND 9 IETTH Amitryptiline NR PM-  Probable Migraine
139 20 F 8 Temporal Pricking 3 Visual MWWOA amt + prop DFI-6M+ TTH-Tension type Head ache
140 19 F 18 Frontal Throbbing 2 MWOA Amit DFI-6M
FETTH-Frequent Episodic Tension type Head 
ache
141 48 M 16 FRONTAL ACHE 10 YES FETTH Amitryptiline DFI-6M
IETTH-Infrequent Episodic Tension type head 
ache
142 18 F 5 Temporal Throbbing 4 MWOA amt + prop DFI-6M+ PTTH- Probable Tension type Head ache
143 27 M 20 FRONTAL ACHE 20 CTTH Amitryptiline DFI-6M CTTH-Chronic Tension type head ache
144 24 M 24 Temporal Throbbing 2 Visual MWA prop DFI-6M TAC- Trigeminal Autonomic Cephalagias
145 28 F 24 FRONTAL BAND 5 PTTH Amitryptiline DIF CCH – Chronic Cluster Headache
146 45 F 24 Temporal Throbbing 20 CM amt + prop DFI-6M+ ECH –Episodic Cluster Headache
147 16 F 12 Temporal Throbbing 5 MWOA amt + prop DFI-6M EPHC – Eposodic Paroxysmal Hemicrania
148 42 F 18 Frontal Throbbing 15 MWOA amt + prop DFI-6M+ CPHC – Chronic Paroxysmal Hemicrania
149 36 M 24 Temporal Pricking 3 MWOA amt + prop DFI-6M+ DFI-12m- Disease free interval  for 12 months
150 53 F 5 OCCIPITAL ACHE 15 YES CTTH Amitryptiline DIF
DFI-6m+ - Disease free interval 6months -12 
months
151 15 F 18 Temporal Throbbing 5 CM prop DFI-6M
DFI-6m - Disease free interval less than 6 
months
152 37 M 3 Frontotemp Aching 30 EPHC Amitryptiline DFI-6M NR – No response
ABBREVIATIONS
F
A
M
I
L
Y
 
H
I
S
T
O
R
Y
C
T
S
C
A
N
 
-
 
B
R
A
I
N
C
O
M
P
L
I
C
A
T
I
O
N
S
D
I
A
G
N
O
S
I
S
F
R
E
Q
U
E
N
C
Y
 
/
 
M
O
N
T
H
A
U
R
A
P
R
O
P
H
Y
L
A
X
R
E
S
P
O
N
S
E
L
O
C
A
T
I
O
N
C
H
A
R
A
C
T
E
R
N
O
A
G
E
S
E
X
D
U
R
A
T
I
O
N
 
I
N
 
H
R
S
153 24 F 18 Occipital Throbbing 2 Visual MWWOA amt + prop DFI-6M+ MWA – Migraine with Aura
154 48 M 16 FRONTAL ACHE 10 YES calcific granuloma FETTH Amitryptiline DFI-6M MWOA – Migraine without Aura
155 28 F 18 Temporal Throbbing 4 Yes MWOA Amit DFI-6M+ MWWOA - Migraine with and without Aura
156 32 M 6 Temporal Throbbing 9 MWOA prop DFI-6M CM-   Complications of Migraine
157 19 F 24 Frontal Throbbing 12 Visual MWWOA amt + prop DFI-6M+ PM-  Probable Migraine
158 14 F 24 Temporal Pricking 4 MWOA amt + prop DFI-6M+ TTH-Tension type Head ache
159 12 M 18 Frontal Throbbing 4 MWOA amt + prop DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
160 25 F 6 Temporal Throbbing 6 Sensory & Visual MWWOA prop DFI-6M
IETTH-Infrequent Episodic Tension type head 
ache
161 18 F 12 Temporal Throbbing 5 visual MWA Amit DFI-12M PTTH- Probable Tension type Head ache
162 38 F 18 TEMPORAL ACHE 20 YES CTTH Amitryptiline DFI-6M+ CTTH-Chronic Tension type head ache
163 20 M 18 Temporal Pricking 4 MWOA amt + prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
164 22 F 14 Parietal Throbbing 2 Visual MWA amt + prop DFI-6M CCH – Chronic Cluster Headache
165 44 F 24 Temporal Throbbing 5 MWOA prop DFI-6M+ ECH –Episodic Cluster Headache
166 18 F 9 Frontal Throbbing 20 CM amt + prop DFI-6M EPHC – Eposodic Paroxysmal Hemicrania
167 16 M 5 Temporal Throbbing 3 Visual MWWOA amt + prop DFI-6M+ CPHC – Chronic Paroxysmal Hemicrania
168 22 M 18 Temporal Throbbing 5 Visual MWWOA amt + prop DFI-6M+ DFI-12m- Disease free interval  for 12 months
169 43 F 7 FRONTAL BAND 11 FETTH Amitryptiline DIF
DFI-6m+ - Disease free interval 6months -12 
months
170 24 M 18 Temporal Throbbing 8 MWOA Amit DFI-6M
DFI-6m - Disease free interval less than 6 
months
171 8 F 24 Temporal Throbbing 12 MWOA amt + prop DIF NR – No response
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172 28 F 24 FRONTAL BAND 5 PTTH Amitryptiline DIF MWA – Migraine with Aura
173 29 F 4 Occipital Aching 7 Visual MWA prop DFI-6M MWOA – Migraine without Aura
174 19 F 24 Temporal Throbbing 4 MWOA amt + prop DFI-6M+ MWWOA - Migraine with and without Aura
175 17 F 18 Temporal Throbbing 8 MWOA amt + prop DFI-6M+ CM-   Complications of Migraine
176 25 F 12 Temporal Pricking 3 Visual MWWOA amt + prop DIF PM-  Probable Migraine
177 37 F 10 FRONTAL BAND 10 FETTH Amitryptiline NR TTH-Tension type Head ache
178 33 F 24 Parietal Throbbing 2 MWOA amt + prop DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
179 39 M 24 Temporal Throbbing 4 MWOA prop DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
180 43 F 18 Temporal Throbbing 2 MWOA amt + prop DIF PTTH- Probable Tension type Head ache
181 18 F 24 Temporal Throbbing 20 MWOA amt + prop DFI-6M+ CTTH-Chronic Tension type head ache
182 46 M 18 Temporal Throbbing 5 gliosis Stroke CM amt + prop DIF TAC- Trigeminal Autonomic Cephalagias
183 26 F 18 Occipital Aching 4 Visual MWWOA amt + prop DFI-6M+ CCH – Chronic Cluster Headache
184 23 F 3 Temporal Burning 8 MWOA prop DFI-6M ECH –Episodic Cluster Headache
185 31 F 6 Frontotemp Aching 30 EPHC Amitryptiline DFI-6M EPHC – Eposodic Paroxysmal Hemicrania
186 40 F 12 Frontal Throbbing 5 MWOA prop DFI-6M CPHC – Chronic Paroxysmal Hemicrania
187 22 M 24 Temporal Throbbing 3 Visual MWA amt + prop DIF DFI-12m- Disease free interval  for 12 months
188 14 M 18 Temporal Pricking 12 Visual MWA prop DFI-6M
DFI-6m+ - Disease free interval 6months -12 
months
189 18 F 2 Temporal Throbbing 7 MWOA amt + prop DFI-6M+
DFI-6m - Disease free interval less than 6 
months
190 32 F 18 Temporal Throbbing 14 Sensory MWWOA amt + prop DFI-6M+ NR – No response
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191 20 F 18 Frontal Throbbing 12 MWOA prop DFI-6M+ MWA – Migraine with Aura
192 45 F 5 Temporal Throbbing 7 Visual MWWOA amt + prop DIF MWOA – Migraine without Aura
193 26 M 15 Temporal Throbbing 24 CM amt + prop DIF MWWOA - Migraine with and without Aura
194 14 F 18 Temporal Pricking 3 MWOA prop DFI-6M CM-   Complications of Migraine
195 18 F 2 Occipital Aching 4 MWOA prop DFI-6M PM-  Probable Migraine
196 52 F 18 Temporal Throbbing 12 Visual MWWOA amt + prop DFI-6M+ TTH-Tension type Head ache
197 19 M 20 Temporal Throbbing 12 CM amt + prop DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
198 27 F 3 Occipital Diffuse 16 Visual MWWOA amt + prop DFI-6M
IETTH-Infrequent Episodic Tension type head 
ache
199 35 F 18 Temporal Throbbing 12 MWOA Amit DFI-12M PTTH- Probable Tension type Head ache
200 42 M 18 Frontal Throbbing 12 MWOA prop DFI-6M+ CTTH-Chronic Tension type head ache
201 14 F 21 Temporal Throbbing 24 CM amt + prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
202 27 M 5MIN Frontotemp Aching 60 EPHC Amitryptiline DFI-6M CCH – Chronic Cluster Headache
203 18 F 3 Temporal Throbbing 8 Visual MWWOA Sod Valp DFI-6M+ ECH –Episodic Cluster Headache
204 20 F 18 Temporal Pricking 12 Yes MWOA amt + prop DFI-12M EPHC – Eposodic Paroxysmal Hemicrania
205 38 M 5 Temporal Throbbing 12 Yes MWOA amt + prop DIF CPHC – Chronic Paroxysmal Hemicrania
206 25 M 18 Parietal Throbbing 24 Yes MWOA Amit DIF DFI-12m- Disease free interval  for 12 months
207 19 F 11 Temporal Pricking 8 Yes MWOA amt + prop DFI-6M+
DFI-6m+ - Disease free interval 6months -12 
months
208 36 F 18 Occipital Throbbing 5 Sensory & Visual Yes MWA prop DFI-6M+
DFI-6m - Disease free interval less than 6 
months
209 42 M 4 Temporal Throbbing 12 MWOA amt + prop DFI-12M NR – No response
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210 18 F 18 Frontal Pricking 24 Yes CM amt + prop DFI-6M+ MWA – Migraine with Aura
211 12 M 18 Temporal Throbbing 14 Visual Yes MWWOA amt + prop DIF MWOA – Migraine without Aura
212 31 F 24 Frontal Throbbing 24 Yes CM amt + prop DFI-6M+ MWWOA - Migraine with and without Aura
213 24 F 3 Temporal Throbbing 12 Visual Yes MWWOA amt + prop DFI-6M+ CM-   Complications of Migraine
214 26 F 18 Frontal Throbbing 12 MWOA prop DFI-6M PM-  Probable Migraine
215 30 F 18 Temporal Pricking 24 Yes MWOA Amit DFI-6M+ TTH-Tension type Head ache
216 34 M 12 Frontal Throbbing 7 Visual MWWOA Amit DFI-6M+
FETTH-Frequent Episodic Tension type Head 
ache
217 34 F 3 Frontal Throbbing 12 Yes MWOA amt + prop DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
218 22 F 18 Frontal Throbbing 12 Visual Yes MWA prop DFI-12M PTTH- Probable Tension type Head ache
219 45 M 3 Frontotemp Aching 30 SUNCT Sod Valp DIF CTTH-Chronic Tension type head ache
220 18 M 18 Temporal Throbbing 6 Yes MWOA amt + prop DIF TAC- Trigeminal Autonomic Cephalagias
221 22 F 14 Frontal Throbbing 2 Visual MWWOA amt + prop DFI-12M CCH – Chronic Cluster Headache
222 26 M 15 Temporal Throbbing 24 Yes CM amt + prop DIF ECH –Episodic Cluster Headache
223 15 F 18 Occipital Pricking 4 Yes MWOA prop DFI-12M EPHC – Eposodic Paroxysmal Hemicrania
224 18 F 2 Temporal Throbbing 14 Visual MWWOA amt + prop DFI-6M+ CPHC – Chronic Paroxysmal Hemicrania
225 38 M 12 Frontotemp Aching 30 CPHC Amitryptiline DIF DFI-12m- Disease free interval  for 12 months
226 36 M 8 Temporal Pricking 24 Yes MWOA Sod Valp DFI-6M+
DFI-6m+ - Disease free interval 6months -12 
months
227 29 M 18 Frontal Throbbing 12 Basal Gang Calc MWOA prop DFI-6M
DFI-6m - Disease free interval less than 6 
months
228 14 F 18 Temporal Burning 24 Visual Yes MWA prop DFI-6M+ NR – No response
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229 18 M 18 Occipital Diffuse 3 Yes MWOA amt + prop DFI-6M+ MWA – Migraine with Aura
230 53 F 24 Temporal Diffuse 18 Yes CM amt + prop DFI-6M+ MWOA – Migraine without Aura
231 22 F 14 Temporal Throbbing 3 Visual Yes Calcif Granuloma MWA amt + prop DIF MWWOA - Migraine with and without Aura
232 34 F 12 Frontal Throbbing 5 Visual Yes MWWOA amt + prop DFI-6M+ CM-   Complications of Migraine
233 43 F 24 Temporal Aching 8 visual Yes MWWOA amt + prop DFI-6M+ PM-  Probable Migraine
234 39 M 3 Frontotemp Aching 15 CPHC Amitryptiline DIF TTH-Tension type Head ache
235 19 M 24 Temporal Pricking 12 CM prop DFI-12M
FETTH-Frequent Episodic Tension type Head 
ache
236 52 F 18 Occipital Throbbing 7 Yes MWOA Amit DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
237 38 F 18 Temporal Throbbing 4 MWOA amt + prop DFI-12M PTTH- Probable Tension type Head ache
238 44 F 24 FRONTAL BAND 5 PTTH Amitryptiline DIF CTTH-Chronic Tension type head ache
239 24 M 8 Frontal Throbbing 8 Yes Calcif Granuloma CM amt + prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
240 22 F 14 Temporal Throbbing 5 Visual Yes MWWOA amt + prop DFI-6M+ CCH – Chronic Cluster Headache
241 19 F 18 Frontal Aching 3 MWOA Amit DFI-12M ECH –Episodic Cluster Headache
242 17 F 24 Temporal Throbbing 2 Yes MWOA amt + prop DFI-6M+ EPHC – Eposodic Paroxysmal Hemicrania
243 29 F 12 Parietal Throbbing 4 Yes MWOA amt + prop DFI-12M CPHC – Chronic Paroxysmal Hemicrania
244 51 M 18 Temporal Throbbing 2 Visual Yes Calcif Granuloma MWWOA amt + prop DIF DFI-12m- Disease free interval  for 12 months
245 19 M 12 Parietal Throbbing 20 Yes CM amt + prop DFI-12M
DFI-6m+ - Disease free interval 6months -12 
months
246 32 F 8 Temporal Diffuse 5 Yes MWOA prop DFI-6M+
DFI-6m - Disease free interval less than 6 
months
247 26 M 24 Frontal Throbbing 4 Visual MWWOA amt + prop DIF NR – No response
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248 39 M 11 OCCIPITAL ACHE 21 CTTH Amitryptiline NR MWA – Migraine with Aura
249 50 F 24 Frontal Throbbing 16 CM amt + prop DFI-6M+ MWOA – Migraine without Aura
250 22 F 5 Occipital Throbbing 8 Yes MWOA Amit DIF MWWOA - Migraine with and without Aura
251 21 F 12 Temporal Throbbing 5 MWOA prop DFI-6M CM-   Complications of Migraine
252 19 M 7 Temporal Aching 3 Yes MWOA amt + prop DIF PM-  Probable Migraine
253 36 M 20MIN Frontal Aching 6 PHSA Amitryptiline DIF TTH-Tension type Head ache
254 24 F 12 Frontal Throbbing 12 Calcif Granuloma MWOA amt + prop DIF
FETTH-Frequent Episodic Tension type Head 
ache
255 35 F 9 PARIETAL ACHE 17 CTTH Amitryptiline DFI-6M
IETTH-Infrequent Episodic Tension type head 
ache
256 35 M 24 Temporal Pricking 7 Visual Yes MWWOA amt + prop DFI-6M+ PTTH- Probable Tension type Head ache
257 16 F 24 Temporal Throbbing 14 Calcif Granuloma MWOA prop DFI-6M+ CTTH-Chronic Tension type head ache
258 17 F 18 Occipital Pricking 1 Visual Yes MWWOA prop DFI-12M TAC- Trigeminal Autonomic Cephalagias
259 15 F 5 Temporal Throbbing 5 Yes CM prop DFI-6M CCH – Chronic Cluster Headache
260 37 F 12 Temporal Throbbing 3 MWOA amt + prop DFI-6M+ ECH –Episodic Cluster Headache
261 53 F 5 OCCIPITAL ACHE 15 YES CTTH Amitryptiline DIF EPHC – Eposodic Paroxysmal Hemicrania
262 50 M 12 Temporal Throbbing 6 Yes CM amt + prop DIF CPHC – Chronic Paroxysmal Hemicrania
263 13 M 8 Frontal Throbbing 2 CM amt + prop DIF DFI-12m- Disease free interval  for 12 months
264 14 F 24 Frontal Throbbing 3 Sensory MWA prop DFI-6M+
DFI-6m+ - Disease free interval 6months -12 
months
265 45 M 24 PARIETAL PRICKING 2 IETTH Amitryptiline DFI-6M
DFI-6m - Disease free interval less than 6 
months
266 15 F 18 Temporal Throbbing 5 Yes CM prop DFI-6M NR – No response
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267 26 F 14 Temporal Throbbing 22 Yes MWOA Amit DFI-12M MWA – Migraine with Aura
268 51 F 8 FRONTAL ACHE 16 CTTH Amitryptiline DFI-6M+ MWOA – Migraine without Aura
269 59 M 30MIN Frontotemp Aching 4 HH Amitryptiline DIF MWWOA - Migraine with and without Aura
270 41 F 7 Temporal Throbbing 20 Yes gliosis Stroke CM amt + prop DFI-6M CM-   Complications of Migraine
271 41 F 9 FRONTAL ACHE 17 CTTH Amitryptiline DFI-6M PM-  Probable Migraine
272 16 F 24 FRONTAL BAND 7 FETTH Amitryptiline DIF TTH-Tension type Head ache
273 32 F 24 Occipital Burning 2 Sensory Yes MWWOA prop DIF
FETTH-Frequent Episodic Tension type Head 
ache
274 28 M 24 Frontal Throbbing 8 Yes MWOA amt + prop DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
275 39 M 11 OCCIPITAL ACHE 21 CTTH Amitryptiline NR PTTH- Probable Tension type Head ache
276 15 M 8 Temporal Throbbing 2 MWOA amt + prop DFI-6M+ CTTH-Chronic Tension type head ache
277 32 F 9 Parietal Throbbing 4 Visual Yes MWA prop DFI-6M TAC- Trigeminal Autonomic Cephalagias
278 21 M 12 Temporal Diffuse 4 Visual Yes MWWOA amt + prop DFI-6M+ CCH – Chronic Cluster Headache
279 17 F 12 Frontal Throbbing 8 Yes Calcif Granuloma MWOA prop DFI-6M ECH –Episodic Cluster Headache
280 43 M 10 TEMPORAL ACHE 17 YES CTTH Amitryptiline DIF EPHC – Eposodic Paroxysmal Hemicrania
281 8 F 24 Temporal Aching 5 Visual Calcif Granuloma MWA prop DFI-6M CPHC – Chronic Paroxysmal Hemicrania
282 37 M 120 Frontotemp Aching 1 NDPH Amitryptiline DIF DFI-12m- Disease free interval  for 12 months
283 36 F 24 FRONTAL BAND 7 FETTH Amitryptiline DIF
DFI-6m+ - Disease free interval 6months -12 
months
284 13 F 6 Occipital Throbbing 3 Yes MWOA prop DFI-6M
DFI-6m - Disease free interval less than 6 
months
285 15 F 18 Temporal Throbbing 4 Yes MWOA amt + prop DFI-12M NR – No response
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286 44 F 7 TEMPORAL ACHE 18 CTTH Amitryptiline DIF MWA – Migraine with Aura
287 29 F 24 Temporal Throbbing 2 Yes MWOA prop DIF MWOA – Migraine without Aura
288 31 F 24 Frontal Throbbing 24 Yes CM amt + prop DFI-6M+ MWWOA - Migraine with and without Aura
289 29 M 12 Frontal Throbbing 3 Visual Yes MWWOA amt + prop DFI-12M CM-   Complications of Migraine
290 42 F 13 FRONTAL BAND 24 CTTH Amitryptiline DFI-6M+ PM-  Probable Migraine
291 15 F 24 Temporal Pricking 2 Calcif Granuloma MWOA amt + prop DFI-6M+ TTH-Tension type Head ache
292 18 M 6 Temporal Burning 4 Yes MWOA amt + prop DFI-6M
FETTH-Frequent Episodic Tension type Head 
ache
293 44 F 18 Parietal Throbbing 2 MWOA prop DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
294 20 F 6 Parietal Throbbing 5 Yes MWOA amt + prop DFI-6M PTTH- Probable Tension type Head ache
295 24 M 24 Temporal Throbbing 15 Yes CM amt + prop DFI-6M CTTH-Chronic Tension type head ache
296 15 F 12 Occipital Pricking 4 MWOA Amit NR TAC- Trigeminal Autonomic Cephalagias
297 26 F 12 Temporal Throbbing 2 Yes MWOA amt + prop DFI-6M CCH – Chronic Cluster Headache
298 45 F 36 TEMPORAL BAND 9 IETTH Amitryptiline NR ECH –Episodic Cluster Headache
299 26 M 15 Temporal Throbbing 24 Yes CM amt + prop DIF EPHC – Eposodic Paroxysmal Hemicrania
300 42 M 96 Frontotemp Aching 3 NDPH Amitryptiline DIF CPHC – Chronic Paroxysmal Hemicrania
301 25 F 24 Occipital Throbbing 3 Yes MWOA prop DFI-6M+ DFI-12m- Disease free interval  for 12 months
302 30 F 12 Temporal Throbbing 2 Visual Yes MWWOA amt + prop DFI-6M
DFI-6m+ - Disease free interval 6months -12 
months
303 32 F 24 Frontal Throbbing 18 Yes CM amt + prop DFI-12M
DFI-6m - Disease free interval less than 6 
months
304 18 F 12 Temporal Pricking 8 MWOA amt + prop DFI-6M NR – No response
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305 47 M 12 Temporal Throbbing 6 Yes Calcif Granuloma MWOA amt + prop DFI-6M MWA – Migraine with Aura
306 22 F 14 Frontal Throbbing 2 Visual MWWOA amt + prop DFI-12M MWOA – Migraine without Aura
307 15 F 24 Temporal Aching 15 Yes CM amt + prop DFI-6M MWWOA - Migraine with and without Aura
308 12 F 18 Temporal Throbbing 8 Yes MWOA Amit DFI-6M CM-   Complications of Migraine
309 21 F 12 Frontal Throbbing 6 Yes MWOA amt + prop DFI-12M PM-  Probable Migraine
310 32 F 24 FRONTAL BAND 7 FETTH Amitryptiline DIF TTH-Tension type Head ache
311 25 F 6 Frontal Throbbing 8 Visual Yes Calcif Granuloma MWWOA amt + prop DFI-6M
FETTH-Frequent Episodic Tension type Head 
ache
312 29 F 18 Occipital Aching 6 Yes MWOA prop DFI-12M
IETTH-Infrequent Episodic Tension type head 
ache
313 19 F 12 Frontal Throbbing 4 MWOA amt + prop DFI-6M PTTH- Probable Tension type Head ache
314 38 F 24 Temporal Throbbing 3 Yes MWOA Amit DFI-6M+ CTTH-Chronic Tension type head ache
315 57 F 13 FRONTAL BAND 24 CTTH Amitryptiline DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
316 22 M 6 Temporal Throbbing 2 Sensory MWWOA prop DFI-6M CCH – Chronic Cluster Headache
317 18 M 18 Temporal Pricking 4 Yes MWOA prop DFI-6M+ ECH –Episodic Cluster Headache
318 35 F 12 Parietal Throbbing 2 Yes MWOA Amit NR EPHC – Eposodic Paroxysmal Hemicrania
319 35 M 1MIN FRONTAL Stabbing 4 PSH Amitryptiline DIF CPHC – Chronic Paroxysmal Hemicrania
320 44 F 24 FRONTAL BAND 19 CTTH Amitryptiline DFI-6M DFI-12m- Disease free interval  for 12 months
321 34 F 24 Temporal Diffuse 2 Yes MWOA prop DFI-6M
DFI-6m+ - Disease free interval 6months -12 
months
322 18 F 24 FRONTAL BAND 7 FETTH Amitryptiline DIF
DFI-6m - Disease free interval less than 6 
months
323 24 F 12 Temporal Pricking 5 Visual MWA amt + prop DFI-6M NR – No response
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324 15 F 24 Frontal Throbbing 20 Yes CM amt + prop DFI-12M MWA – Migraine with Aura
325 9 F 12 Frontal Throbbing 6 Yes Calcif Granuloma MWOA amt + prop DFI-6M MWOA – Migraine without Aura
326 39 M 11 OCCIPITAL BAND 21 CTTH Amitryptiline NR MWWOA - Migraine with and without Aura
327 20 F 6 Frontal Throbbing 6 Yes MWOA Sod Valp DIF CM-   Complications of Migraine
328 25 M 18 Temporal Aching 4 Visual Yes MWWOA Amit DFI-12M PM-  Probable Migraine
329 17 M 24 Temporal Throbbing 3 Yes MWOA amt + prop DFI-6M TTH-Tension type Head ache
330 39 M 11 OCCIPITAL ACHE 21 CTTH Amitryptiline NR
FETTH-Frequent Episodic Tension type Head 
ache
331 15 M 6 Parietal Throbbing 15 Calcif Granuloma CM amt + prop DFI-6M
IETTH-Infrequent Episodic Tension type head 
ache
332 37 F 18 Temporal Throbbing 2 Sensory Yes Calcif Granuloma MWWOA prop DIF PTTH- Probable Tension type Head ache
333 19 F 6 Temporal Throbbing 6 MWOA prop DIF CTTH-Chronic Tension type head ache
334 25 F 24 Occipital Aching 6 Yes MWOA amt + prop DFI-12M TAC- Trigeminal Autonomic Cephalagias
335 39 F 12 Frontal Throbbing 2 Yes MWOA amt + prop DFI-6M CCH – Chronic Cluster Headache
336 29 F 12 Temporal Throbbing 6 Visual MWWOA prop DFI-12M ECH –Episodic Cluster Headache
337 12 F 24 Temporal Throbbing 2 Yes MWOA amt + prop DFI-6M EPHC – Eposodic Paroxysmal Hemicrania
338 44 F 126 Frontal Throbbing 18 Yes Calcif Granuloma CM prop DIF CPHC – Chronic Paroxysmal Hemicrania
339 17 M 24 Temporal Burning 2 Sensory & Visual Yes MWWOA prop DFI-6M+ DFI-12m- Disease free interval  for 12 months
340 29 M 1MIN FRONTAL Stabbing 6 PSH Amitryptiline DIF
DFI-6m+ - Disease free interval 6months -12 
months
341 22 M 18 Occipital Throbbing 3 Yes MWOA amt + prop DFI-12M
DFI-6m - Disease free interval less than 6 
months
342 23 M 12 Frontal Aching 16 Yes CM amt + prop DFI-6M NR – No response
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343 42 F 13 FRONTAL ACHE 24 CTTH Amitryptiline DFI-6M+ MWA – Migraine with Aura
344 28 F 6 Frontal Throbbing 15 Yes MWOA amt + prop DFI-6M MWOA – Migraine without Aura
345 36 F 12 Temporal Pricking 5 Visual MWWOA Amit NR MWWOA - Migraine with and without Aura
346 19 F 24 Occipital Throbbing 3 Yes Calcif Granuloma MWOA amt + prop DFI-12M CM-   Complications of Migraine
347 49 F 9 FRONTAL ACHE 17 calcific granuloma CTTH Amitryptiline DFI-6M PM-  Probable Migraine
348 24 F 18 Temporal Throbbing 2 MWOA amt + prop DFI-6M TTH-Tension type Head ache
349 20 M 12 Frontal Throbbing 5 Yes MWOA prop DIF
FETTH-Frequent Episodic Tension type Head 
ache
350 28 F 12 Temporal Aching 5 Yes CM amt + prop DFI-6M
IETTH-Infrequent Episodic Tension type head 
ache
351 22 F 24 Temporal Pricking 3 Yes MWOA amt + prop DFI-12M PTTH- Probable Tension type Head ache
352 38 M 12 Occipital Throbbing 2 Yes MWOA amt + prop DFI-6M CTTH-Chronic Tension type head ache
353 41 M 15 FRONTAL ACHE 12 YES calcific granuloma IETTH Amitryptiline DIF TAC- Trigeminal Autonomic Cephalagias
354 52 M 16 FRONTAL ACHE 10 YES FETTH Amitryptiline DFI-6M CCH – Chronic Cluster Headache
355 18 F 24 Temporal Throbbing 20 Visual Yes MWWOA prop DIF ECH –Episodic Cluster Headache
356 32 M 96 Frontotemp Aching 2 NDPH Amitryptiline DIF EPHC – Eposodic Paroxysmal Hemicrania
357 21 F 24 Frontal Throbbing 3 Yes MWOA amt + prop DFI-12M CPHC – Chronic Paroxysmal Hemicrania
358 17 M 12 Parietal Throbbing 5 Visual Calcif Granuloma MWA prop DIF DFI-12m- Disease free interval  for 12 months
359 48 M 16 FRONTAL ACHE 10 YES calcific granuloma FETTH Amitryptiline DFI-6M
DFI-6m+ - Disease free interval 6months -12 
months
360 32 F 12 Temporal Pricking 3 Yes MWOA Amit DFI-6M+
DFI-6m - Disease free interval less than 6 
months
361 18 F 6 Occipital Throbbing 2 Visual Yes MWWOA prop DFI-6M+ NR – No response
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362 34 F 6 Temporal Pricking 2 MWOA Amit DFI-6M MWA – Migraine with Aura
363 7 F 12 Temporal Pricking 6 Visual MWA prop DIF MWOA – Migraine without Aura
364 19 M 20 Temporal Throbbing 12 CM amt + prop DFI-6M+ MWWOA - Migraine with and without Aura
365 52 F 2 Temporal Throbbing 12 Visual Yes Calcif Granuloma MWWOA amt + prop DFI-6M+ CM-   Complications of Migraine
366 18 F 12 Frontal Throbbing 15 Yes Calcif Granuloma CM amt + prop DFI-12M PM-  Probable Migraine
367 24 F 24 Temporal Throbbing 2 Visual Yes MWWOA amt + prop DFI-6M TTH-Tension type Head ache
368 36 F 12 Frontal Throbbing 2 Yes MWOA amt + prop DFI-6M
FETTH-Frequent Episodic Tension type Head 
ache
369 18 F 24 Temporal Throbbing 20 Visual Yes MWWOA prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
370 29 F 24 Frontal Throbbing 18 Yes CM amt + prop DFI-6M PTTH- Probable Tension type Head ache
371 27 M 6 Occipital Diffuse 6 Visual Yes MWWOA prop DIF CTTH-Chronic Tension type head ache
372 22 M 6 Occipital Throbbing 4 Sensory MWWOA amt + prop DFI-12M TAC- Trigeminal Autonomic Cephalagias
373 24 F 12 Temporal Pricking 6 Yes MWOA amt + prop DFI-6M CCH – Chronic Cluster Headache
374 36 F 24 Temporal Throbbing 2 Visual Yes MWWOA Amit NR ECH –Episodic Cluster Headache
375 36 F 15 Frontal Throbbing 22 CM amt + prop DFI-6M+ EPHC – Eposodic Paroxysmal Hemicrania
376 32 F 12 Temporal Throbbing 11 Sensory Yes Calcif Granuloma MWWOA amt + prop DFI-6M CPHC – Chronic Paroxysmal Hemicrania
377 28 F 24 Frontal Aching 8 Yes Calcif Granuloma MWOA amt + prop DFI-6M DFI-12m- Disease free interval  for 12 months
378 18 M 12 Temporal Throbbing 2 Yes MWOA amt + prop DFI-6M
DFI-6m+ - Disease free interval 6months -12 
months
379 15 F 12 Temporal Pricking 18 Yes CM amt + prop DFI-6M
DFI-6m - Disease free interval less than 6 
months
380 28 M 6 Temporal Throbbing 1 Visual Yes MWWOA amt + prop DFI-6M NR – No response
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381 28 F 24 FRONTAL BAND 5 calcific granuloma PTTH Amitryptiline DIF MWA – Migraine with Aura
382 19 F 6 Temporal Burning 4 Yes MWOA prop DFI-12M MWOA – Migraine without Aura
383 19 M 24 Frontal Pricking 4 Yes MWOA Amit DFI-6M+ MWWOA - Migraine with and without Aura
384 48 M 16 FRONTAL BAND 10 YES FETTH Amitryptiline DFI-6M CM-   Complications of Migraine
385 33 F 24 Frontal Throbbing 3 Yes Calcif Granuloma MWOA Amit DFI-6M PM-  Probable Migraine
386 53 F 12 Occipital Throbbing 6 Visual MWWOA Amit DFI-6M TTH-Tension type Head ache
387 36 F 6 FRONTAL ACHE 4 YES PTTH Amitryptiline DIF
FETTH-Frequent Episodic Tension type Head 
ache
388 27 M 24 Temporal Throbbing 3 Yes MWOA prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
389 15 F 24 Frontal Throbbing 4 MWOA amt + prop DFI-6M PTTH- Probable Tension type Head ache
390 33 F 24 Temporal Throbbing 22 Yes CM amt + prop DFI-12M CTTH-Chronic Tension type head ache
391 16 M 12 Temporal Throbbing 6 Yes MWOA Amit DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
392 47 F 24 FRONTAL ACHE 10 FETTH Amitryptiline DFI-6M CCH – Chronic Cluster Headache
393 ECH –Episodic Cluster Headache
394 26 F 24 Parietal Throbbing 5 Visual Yes MWWOA amt + prop DFI-12M EPHC – Eposodic Paroxysmal Hemicrania
395 18 F 6 Temporal Pricking 2 Yes MWOA amt + prop DFI-6M CPHC – Chronic Paroxysmal Hemicrania
396 32 M 24 Temporal Aching 6 Visual Yes Calcif Granuloma MWA prop DIF DFI-12m- Disease free interval  for 12 months
397 10 F 12 Temporal Throbbing 4 Yes MWOA Amit DFI-6M+
DFI-6m+ - Disease free interval 6months -12 
months
398 42 F 13 FRONTAL ACHE 24 CTTH Amitryptiline DFI-6M+
DFI-6m - Disease free interval less than 6 
months
399 36 F 6 Temporal Aching 3 Visual Yes Calcif Granuloma MWA prop DIF NR – No response
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400 35 M 24 Frontal Aching 15 Yes CM amt + prop DFI-12M MWA – Migraine with Aura
401 45 M 24 PARIETAL ACHE 2 IETTH Amitryptiline DFI-6M MWOA – Migraine without Aura
402 18 F 6 Occipital Throbbing 2 Visual Yes MWWOA prop DFI-6M+ MWWOA - Migraine with and without Aura
403 42 F 24 Frontal Throbbing 5 MWOA amt + prop DIF CM-   Complications of Migraine
404 16 F 12 Temporal Pricking 3 Yes Calcif Granuloma MWOA Amit DFI-12M PM-  Probable Migraine
405 30 M 6 Temporal Throbbing 2 Sensory & Visual Calcif Granuloma MWA amt + prop DFI-6M TTH-Tension type Head ache
406 20 M 24 Frontal Aching 8 Yes MWOA amt + prop DFI-12M
FETTH-Frequent Episodic Tension type Head 
ache
407 15 F 12 Temporal Pricking 18 Yes CM amt + prop DFI-6M
IETTH-Infrequent Episodic Tension type head 
ache
408 52 F 6 Temporal Throbbing 6 Sensory Yes MWWOA amt + prop DFI-6M PTTH- Probable Tension type Head ache
409 28 F 24 FRONTAL BAND 5 calcific granuloma PTTH Amitryptiline DIF CTTH-Chronic Tension type head ache
410 18 F 12 Parietal Throbbing 4 Yes MWOA prop DIF TAC- Trigeminal Autonomic Cephalagias
411 16 F 24 Temporal Pricking 8 Visual MWWOA Amit DFI-6M CCH – Chronic Cluster Headache
412 41 M 20 FRONTAL ACHE 20 CTTH Amitryptiline DFI-6M ECH –Episodic Cluster Headache
413 24 M 24 Frontal Throbbing 18 Yes Calcif Granuloma CM amt + prop DFI-12M EPHC – Eposodic Paroxysmal Hemicrania
414 40 F 6 Parietal Throbbing 10 Yes MWOA amt + prop DFI-6M CPHC – Chronic Paroxysmal Hemicrania
415 25 M 6 Temporal Throbbing 4 Visual Yes MWWOA amt + prop DFI-6M DFI-12m- Disease free interval  for 12 months
416 30 F 12 Temporal Aching 2 Visual MWA prop DIF
DFI-6m+ - Disease free interval 6months -12 
months
417 26 M 12 Frontal Throbbing 4 Yes Calcif Granuloma MWOA amt + prop DFI-12M
DFI-6m - Disease free interval less than 6 
months
418 56 F 4 FRONTAL ACHE 8 YES FETTH Amitryptiline DFI-6M+ NR – No response
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419 18 F 5 Frontal Throbbing 20 Yes CM amt + prop DFI-6M MWA – Migraine with Aura
420 20 F 12 Temporal Throbbing 2 Yes MWOA prop DIF MWOA – Migraine without Aura
421 51 F 24 Occipital Diffuse 2 Yes MWOA Amit DFI-6M+ MWWOA - Migraine with and without Aura
422 44 F 24 PARIETAL ACHE 16 YES CTTH Amitryptiline DFI-12M CM-   Complications of Migraine
423 12 M 6 Temporal Throbbing 1 Yes MWOA prop DFI-12M PM-  Probable Migraine
424 19 M 12 Temporal Throbbing 4 MWOA amt + prop DFI-6M TTH-Tension type Head ache
425 26 F 7 TEMPORAL ACHE 18 CTTH Amitryptiline DIF
FETTH-Frequent Episodic Tension type Head 
ache
426 26 F 12 Temporal Throbbing 2 Visual Yes MWWOA amt + prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
427 PTTH- Probable Tension type Head ache
428 42 F 22 FRONTAL BAND 15 CTTH Amitryptiline DIF CTTH-Chronic Tension type head ache
429 15 F 24 Frontal Throbbing 15 CM amt + prop DIF TAC- Trigeminal Autonomic Cephalagias
430 33 F 6 Occipital Pricking 2 Yes MWOA prop DFI-6M+ CCH – Chronic Cluster Headache
431 34 M 4 TEMPORAL ACHE 16 YES CTTH Amitryptiline DFI-12M ECH –Episodic Cluster Headache
432 27 M 6 Occipital Throbbing 3 Visual Yes Calcif Granuloma MWWOA amt + prop DIF EPHC – Eposodic Paroxysmal Hemicrania
433 35 F 12 Temporal Burning 4 Sensory MWWOA amt + prop DIF CPHC – Chronic Paroxysmal Hemicrania
434 40 M 24 Occipital Throbbing 4 Yes MWOA amt + prop DFI-6M DFI-12m- Disease free interval  for 12 months
435 45 M 24 FRONTAL ACHE 2 IETTH Amitryptiline DFI-6M
DFI-6m+ - Disease free interval 6months -12 
months
436 18 F 24 Temporal Throbbing 6 Yes MWOA prop DIF
DFI-6m - Disease free interval less than 6 
months
437 38 M 9 FRONTAL BAND 2 YES calcific granuloma PTTH Amitryptiline DFI-6M+ NR – No response
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438 30 F 6 Occipital Throbbing 7 Sensory Calcif Granuloma MWWOA prop DFI-6M+ MWA – Migraine with Aura
439 25 F 12 Temporal Pricking 8 Yes MWOA Amit DFI-6M+ MWOA – Migraine without Aura
440 53 M 20 FRONTAL ACHE 20 CTTH Amitryptiline DFI-6M MWWOA - Migraine with and without Aura
441 23 M 12 Frontal Aching 16 Yes CM amt + prop DFI-6M CM-   Complications of Migraine
442 35 F 24 Temporal Throbbing 8 Yes MWOA amt + prop DFI-12M PM-  Probable Migraine
443 33 M 24 FRONTAL ACHE 15 CTTH Amitryptiline DFI-6M+ TTH-Tension type Head ache
444 26 F 12 Frontal Throbbing 8 Yes MWOA Amit DFI-6M
FETTH-Frequent Episodic Tension type Head 
ache
445 56 F 4 FRONTAL ACHE 8 YES FETTH Amitryptiline DFI-6M+
IETTH-Infrequent Episodic Tension type head 
ache
446 22 F 6 Frontal Aching 4 visual Yes Calcif Granuloma MWA prop DIF PTTH- Probable Tension type Head ache
447 25 F 24 Parietal Throbbing 3 Visual Yes Calcif Granuloma MWWOA amt + prop DIF CTTH-Chronic Tension type head ache
448 17 F 6 Temporal Pricking 2 Yes Calcif Granuloma MWOA amt + prop DIF TAC- Trigeminal Autonomic Cephalagias
449 29 M 3 FRONTAL BAND 20 CTTH Amitryptiline DFI-6M CCH – Chronic Cluster Headache
450 28 F 24 Frontal Throbbing 5 Visual Yes MWA prop DFI-12M ECH –Episodic Cluster Headache
451 14 M 6 Parietal Throbbing 3 Yes MWOA prop DFI-6M+ EPHC – Eposodic Paroxysmal Hemicrania
452 20 F 12 Temporal Pricking 8 Yes MWOA amt + prop DFI-12M CPHC – Chronic Paroxysmal Hemicrania
453 26 M 24 Frontal Throbbing 6 Yes MWOA Amit DFI-6M+ DFI-12m- Disease free interval  for 12 months
454 15 F 6 Occipital Throbbing 4 Yes MWOA amt + prop DFI-12M
DFI-6m+ - Disease free interval 6months -12 
months
455 26 F 24 Temporal Pricking 2 Visual Yes MWWOA amt + prop DIF
DFI-6m - Disease free interval less than 6 
months
456 19 F 6 Temporal Throbbing 4 Yes MWOA amt + prop DIF NR – No response
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457 30 F 24 Temporal Aching 11 MWOA amt + prop DFI-12M MWA – Migraine with Aura
458 25 M 12 Frontal Throbbing 2 Visual Yes MWWOA amt + prop DIF MWOA – Migraine without Aura
459 38 M 24 Temporal Diffuse 20 Yes CM amt + prop DIF MWWOA - Migraine with and without Aura
460 15 F 6 Temporal Throbbing 1 Visual MWWOA prop DFI-12M CM-   Complications of Migraine
461 24 F 12 Frontal Throbbing 4 Yes MWOA amt + prop DIF PM-  Probable Migraine
462 18 F 9 FRONTAL ACHE 17 calcific granuloma CTTH Amitryptiline DFI-6M TTH-Tension type Head ache
463 28 F 24 Temporal Aching 2 Visual Yes MWWOA amt + prop DFI-12M
FETTH-Frequent Episodic Tension type Head 
ache
464 26 F 24 Temporal Throbbing 4 Yes MWOA amt + prop DFI-12M
IETTH-Infrequent Episodic Tension type head 
ache
465 40 M 24 Temporal Pricking 8 Yes Calcif Granuloma MWOA Amit DFI-12M PTTH- Probable Tension type Head ache
466 34 M 4 TEMPORAL ACHE 16 YES CTTH Amitryptiline DFI-12M CTTH-Chronic Tension type head ache
467 40 F 6 Parietal Throbbing 7 Yes PM prop DFI-6M+ TAC- Trigeminal Autonomic Cephalagias
468 18 F 6 Temporal Throbbing 9 Visual Yes MWWOA amt + prop DIF CCH – Chronic Cluster Headache
469 14 F 24 Temporal Throbbing 4 Visual Yes MWWOA amt + prop DFI-12M ECH –Episodic Cluster Headache
470 26 F 12 Frontal Aching 4 MWOA amt + prop DIF EPHC – Eposodic Paroxysmal Hemicrania
471 43 F 32 FRONTAL ACHE 17 CTTH Amitryptiline DFI-6M+ CPHC – Chronic Paroxysmal Hemicrania
472 19 M 12 Temporal Throbbing 8 Yes MWOA amt + prop DFI-12M DFI-12m- Disease free interval  for 12 months
473 22 F 6 Temporal Burning 7 MWOA amt + prop DIF
DFI-6m+ - Disease free interval 6months -12 
months
474 48 M 16 FRONTAL ACHE 10 YES calcific granuloma FETTH Amitryptiline DFI-6M
DFI-6m - Disease free interval less than 6 
months
475 28 F 6 Occipital Throbbing 4 Sensory Yes MWWOA prop DFI-12M NR – No response
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476 13 M 24 Frontal Throbbing 8 Yes MWOA amt + prop DIF MWA – Migraine with Aura
477 28 F 24 FRONTAL BAND 5 calcific granuloma PTTH Amitryptiline DIF MWOA – Migraine without Aura
478 30 F 6 Occipital Throbbing 7 Sensory Calcif Granuloma MWWOA prop DFI-6M+ MWWOA - Migraine with and without Aura
479 15 F 6 Temporal Pricking 9 Yes PM amt + prop DIF CM-   Complications of Migraine
480 34 M 4 TEMPORAL ACHE 16 YES CTTH Amitryptiline DFI-12M PM-  Probable Migraine
481 19 M 24 Frontal Pricking 4 Yes MWOA Amit DFI-6M+ TTH-Tension type Head ache
482 25 F 7 TEMPORAL ACHE 27 YES CTTH Amitryptiline DFI-12M
FETTH-Frequent Episodic Tension type Head 
ache
483 27 F 12 Frontal Throbbing 2 Visual Yes Calcif Granuloma MWWOA amt + prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
484 22 F 12 Parietal Throbbing 5 Visual Yes MWWOA amt + prop DIF PTTH- Probable Tension type Head ache
485 38 M 24 Temporal Diffuse 20 Yes CM amt + prop DIF CTTH-Chronic Tension type head ache
486 38 F 20 OCCIPITAL ACHE 3 calcific granuloma IETTH Amitryptiline DFI-6M TAC- Trigeminal Autonomic Cephalagias
487 22 F 15 FRONTAL ACHE 12 YES calcific granuloma IETTH Amitryptiline DIF CCH – Chronic Cluster Headache
488 30 F 6 Frontal Throbbing 14 Yes MWOA amt + prop DFI-12M ECH –Episodic Cluster Headache
489 31 F 24 Frontal Throbbing 24 Yes CM amt + prop DFI-6M+ EPHC – Eposodic Paroxysmal Hemicrania
490 40 F 6 Parietal Throbbing 7 Yes PM prop DFI-6M+ CPHC – Chronic Paroxysmal Hemicrania
491 24 F 9 FRONTAL ACHE 17 calcific granuloma CTTH Amitryptiline DFI-6M DFI-12m- Disease free interval  for 12 months
492 17 M 24 Temporal Pricking 3 Visual Yes Calcif Granuloma MWWOA prop DIF
DFI-6m+ - Disease free interval 6months -12 
months
493 24 F 6 Temporal Throbbing 9 Sensory & Visual Yes MWWOA amt + prop DFI-6M
DFI-6m - Disease free interval less than 6 
months
494 47 F 24 FRONTAL ACHE 10 calcific granuloma FETTH Amitryptiline DFI-6M NR – No response
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495 36 F 24 Temporal Aching 15 Yes MWOA amt + prop DIF MWA – Migraine with Aura
496 22 F 12 Frontal Throbbing 12 PM amt + prop DFI-6M MWOA – Migraine without Aura
497 56 F 13 FRONTAL ACHE 24 CTTH Amitryptiline DFI-6M+ MWWOA - Migraine with and without Aura
498 24 F 24 FRONTAL BAND 7 calcific granuloma FETTH Amitryptiline DIF CM-   Complications of Migraine
499 26 F 7 TEMPORAL ACHE 18 CTTH Amitryptiline DIF PM-  Probable Migraine
500 14 M 24 Temporal Throbbing 3 MWOA prop DFI-6M TTH-Tension type Head ache
501 29 M 3 FRONTAL BAND 20 CTTH Amitryptiline DFI-6M
FETTH-Frequent Episodic Tension type Head 
ache
502 18 M 6 Occipital Throbbing 4 Yes MWOA prop DIF
IETTH-Infrequent Episodic Tension type head 
ache
International Headache Society Classification of Migraine (2004) 
1.1 Migraine without aura 
 1.2 Migraine with aura 
1.2.1 Typical aura with migraine headache 
1.2.2 Typical aura with non-migraine headache 
1.2.3 Typical aura without headache 
1.2.4 Familial hemiplegic migraine (FHM) 
1.2.5 Sporadic hemiplegic migraine 
1.2.6 Basilar-type migraine 
 1.3 Childhood periodic syndromes that are commonly precursors of migraine 
1.3.1 Cyclical vomiting 
1.3.2 Abdominal migraine 
1.3.3 Benign paroxysmal vertigo of childhood 
 1.4 Retinal migraine 
 1.5 Complications of migraine 
1.5.1 Chronic migraine 
1.5.2 Status migrainosus 
1.5.3 Persistent aura without infarction 
1.5.4 Migrainous infarction 
1.5.5 Migraine-triggered seizures 
 1.6 Probable migraine 
1.6.1 Probable migraine without aura 
1.6.2 Probable migraine with aura 
1.6.5 Probable chronic migraine 
International Headache Society Diagnosis Criteria for Migraine 
1.1 Migraine without aura: This is a clinical syndrome characterised by recurrent headache 
disorder manifesting in attacks lasting 4-72 hours, with typical headache of unilateral location, 
pulsating quality, moderate or severe intensity, aggravation by routine physical activity and 
association with nausea and/or photophobia and phonophobia. The diagnostic criteria include: 
(A) At least 5 attacks fulfilling criteria B-D; (B) Headache attacks lasting 4-72 hours (untreated 
or unsuccessfully treated); (C) Headache has at least two of the following characteristics: 1. 
unilateral location, 2. pulsating quality, 3. moderate or severe pain intensity, 4. aggravation by or 
causing avoidance of routine physical activity (eg, walking or climbing stairs); (D) During 
headache at least one of the following: 1. nausea and/or vomiting, 2. photophobia and 
phonophobia; and (E) Not attributed to another disorder 
1.2 Migraine with aura: This entity previously termed classical migraine is a recurrent 
disorder of reversible focal neurological symptoms that develops gradually over 5-20 minutes 
and last for less than 60 minutes,. Headache with features of migraine without aura usually 
follows the aura symptoms, and less commonly, headache lacks migrainous features or is 
completely absent. The aura is a complex of neurological symptoms that occurs just before or at 
the onset of migraine headache. Most patients with migraine have exclusively attacks without 
aura. Many patients who have frequent attacks with aura may also have attacks without aura. 
Diagnostic criteria include [A] At least 2 attacks fulfilling criterion B [B] Migraine aura fulfilling 
criteria B and C for one of the subforms 1.2.1-1.2.6 & [C] Not attributed to another disorder. 
Premonitory symptoms occur hours to a day or two before a migraine attack (with or without 
aura), that include various combinations of fatigue, difficulty in concentrating, neck stiffness, 
sensitivity to light or sound, nausea, blurred vision, yawning and pallor. Auras with similar 
feature are also described in other well-defined headache types like cluster headache.  
1.2.1 Migraine with typical aura: Typical aura consists of visual and/or sensory and/or 
speech symptoms. Gradual development, duration no longer than one hour, a mix of positive and 
negative features and complete reversibility characterise the aura which is associated with a 
headache fulfilling criteria for Migraine without aura. Diagnostic criteria include (A) At least 2 
attacks fulfilling criteria B–D; (B) Aura consisting of at least one of the following, but no motor 
weakness: 1. fully reversible visual symptoms including positive features (eg, flickering lights, 
spots or lines) and/or negative features (ie, loss of vision), 2. fully reversible sensory symptoms 
including positive features (ie, pins and needles) and/or negative features (ie, numbness), 3. fully 
reversible dysphasic speech disturbance; (C) At least two of the following: 1. homonymous 
visual symptoms and/or unilateral sensory symptoms 2. at least one aura symptom develops 
gradually over ≥5 minutes and/or different aura symptoms occur in succession over ≥5 minutes, 
3. each symptom lasts ≥5 and ≤60 minutes; (D) Headache fulfilling criteria B-D for 1.1 Migraine 
without aura begins during the aura or follows aura within 60 minutes; (E) Not attributed to 
another disorder. This is the most common migraine syndrome associated with aura, the 
diagnosis of which is evident with careful history alone, but rarely carotid dissection, AV 
malformation and seizure may mimic this condition. Aura include visual aura, the most common 
type that often presents as a fortification spectrum or scotoma without positive phenomena; 
sensory aura, that presents as pins and needles moving slowly from the point of origin or 
numbness and speech disturbances like dysphasia. Symptoms usually follow one another in 
succession beginning with visual, then sensory symptoms and dysphasia.  
 1.2.2 : Typical aura with non-migraine headache: Typical aura consisting of visual 
and/or sensory and/or speech symptoms with gradual development, duration no longer than one 
hour, a mix of positive and negative features and complete reversibility characterise the aura 
which is associated with a headache that does not fulfil criteria for 1.1 Migraine without aura. 
Diagnostic criteria includes all patterns as for Migraine with typical aura from A – C and a 
Headache that does not fulfil the criteria B-D set for 1.1 Migraine without aura, that  begins 
during the aura or follows aura within 60 minutes. In the absence of headache fulfilling the 
criteria for 1.1 Migraine without aura, precise diagnosis of aura and its distinction from more 
serious diseases like transient ischemic attack becomes more important. 
 1.2.3: Typical aura without headache: Typical aura consisting of visual and/or sensory 
symptoms with or without speech symptoms. Gradual development, duration no longer than one 
hour, a mix of positive and negative features and complete reversibility characterise the aura 
which is not associated with headache. A small number of patients have typical aura without 
headache are commonly patients with Typical aura with migraine who on becoming older have 
lost migraine characteristics, even though auras continue. Diagnostic criteria includes all patterns 
as for Migraine with typical aura from A – C without Headache during the aura or following aura 
within 60 minutes.  
 1.2.4:  Familial hemiplegic migraine (FHM): Migraine with aura including motor 
weakness and at least one first- or second-degree relative has migraine aura including motor 
weakness. Specific genetic subtypes of FHM have been identified: (1) FHM1 - mutations in 
CACNA1A gene on chromosome 19 (2) FHM2 - mutations in the ATP1A2 gene on 
chromosome1, of these FHM1 very often has basilar-type symptoms in addition to the typical 
aura while headache is virtually always present. 
 1.2.5 Sporadic hemiplegic migraine: Migraine with aura including motor weakness 
without first or second-degree relative having an aura including motor weakness. The attacks 
have the same clinical characteristics as those in FHM.  
 1.2.6 Basilar-type migraine: Previously termed as Basilar artery migraine or basilar 
migraine, this entity is migraine with aura symptoms clearly originating from the brainstem 
and/or from both hemispheres simultaneously affected, but no motor weakness. Diagnostic 
criteria include: A. At least 2 attacks fulfilling criteria B-D; B. Aura consisting of at least two 
of the following fully reversible symptoms, but no motor weakness: [1] dysarthria [2] vertigo [3] 
tinnitus [4] hypacusia [5] diplopia [6] visual symptoms simultaneously in both temporal and 
nasal fields of both eyes [7] ataxia [8] decreased level of consciousness [9] simultaneously 
bilateral paraesthesias; C. At least one of the following: [1] at least one aura symptom develops 
gradually over ≥5 minutes and/or different aura symptoms occur in succession over ≥5 minutes 
[2] each aura symptom lasts ≥5 and ≤60 minutes; D.Headache fulfilling criteria B-D for 1.1 
Migraine without aura begins during the aura or follows aura within 60 minutes; E. Not 
attributed to another disorder.  
1.3 Childhood periodic syndromes that are commonly precursors of migraine.  
 1.3.1  Cyclical vomiting: Recurrent episodic attacks, usually stereotypical in the 
individual patient, of vomiting and intense nausea. Attacks are associated with pallor and 
lethargy. There is complete resolution of symptoms between attacks. Cyclical vomiting is a self-
limiting episodic condition of childhood, with periods of complete normality between episodes  
 1.3.2  Abdominal migraine: An idiopathic recurrent disorder seen mainly in children 
and characterised by episodic midline abdominal pain manifesting in attacks lasting 1-72 hours 
with normality between episodes. The pain is of moderate to severe intensity and associated with 
vasomotor symptoms, nausea and vomiting.  
 1.3.3  Benign paroxysmal vertigo of childhood: This probably heterogeneous disorder 
is characterised by recurrent brief episodic attacks of vertigo occurring without warning and 
resolving spontaneously in otherwise healthy children.  
1.4 Retinal migraine: Repeated attacks of monocular visual disturbance, including 
scintillations, scotomata or blindness, associated with migraine headache.  
1.5 Complications of migraine 
1.5.1 Chronic migraine: Migraine headache occurring on 15 or more days per month 
for more than 3 months in the absence of medication overuse. Diagnostic criteria: [A] Headache 
fulfilling criteria C and D for 1.1 Migraine without aura on ≥15 days/month for >3 months. [B] 
Not attributed to another disorder. Most cases of chronic migraine start as 1.1 Migraine without 
aura and therefore, may be regarded as a complication of episodic migraine. As chronicity 
develops, headache tends to lose its attack-wise (episodic) presentation although it has not been 
clearly demonstrated that this is always so. Therefore, the default rule is to code such patients 
according to the antecedent migraine subtype plus probable chronic migraine plus probable 
medication-overuse headache.  
1.5.2 Status migrainosus: A debilitating migraine attack lasting for more than 72 
hours. Diagnostic criteria: [A] The present attack in a patient with 1.1 Migraine without aura is 
typical of previous attacks except for its duration [B] Headache has both of the following 
features: (1) unremitting for >72 hours (2) severe intensity [C] Not attributed to another disorder.  
1.5.3 Persistent aura without infarction: Aura symptoms persist for more than 1 
week without radiographic evidence of infarction. Diagnostic criteria: [A].The present attack in a 
patient with 1.2 Migraine with aura is typical of previous attacks except that one or more aura 
symptoms persists for >1 week [B]. Not attributed to another disorder. Persisting aura symptoms 
are rare but well documented. They are often bilateral and may last for months or years. Reliably 
effective treatment is not known though acetazolamide and valproic acid have helped in a few 
cases. It is important to exclude posterior leukoencephalopathy by diffusion MRI and 
Migrainous infarction.  
1.5.4 Migrainous infarction: One or more migrainous aura symptoms associated with 
an ischaemic brain lesion in appropriate territory demonstrated by neuroimaging. Diagnostic 
criteria: [A] The present attack in a patient with 1.2 Migraine with aura is typical of previous 
attacks except that one or more aura symptoms persists for >60 minutes [B] Neuroimaging 
demonstrates ischaemic infarction in a relevant area. [C] Not attributed to another disorder. 
Ischaemic stroke in a migraine sufferer may be categorised as cerebral infarction of other cause 
coexisting with migraine, cerebral infarction of other cause presenting with symptoms 
resembling migraine with aura, or cerebral infarction occurring during the course of a typical 
migraine with aura attack. Only the last fulfils criteria for 1.5.4 Migrainous infarction. Increased 
risk for stroke in migraine patients has been demonstrated in women under age 45 in several 
studies. Evidence for an association between migraine and stroke in older women and in men is 
inconsistent.  
1.5.5 Migraine-triggered seizure: A seizure triggered by a migraine aura. Diagnostic 
criteria: [A]  Migraine fulfilling criteria for 1.2 Migraine with aura [B] A seizure fulfilling 
diagnostic criteria for one type of epileptic attack occurs during or within 1 hour after a migraine 
aura. Migraine and epilepsy are highly comorbid conditions probably sharing the same 
pathophysiology, but the nature of their association is unclear. Migralepsy is the term used when 
a seizure occurs during or within 1 hour of a typical migraine aura attack. Reversible brain MRI 
abnormalities have been reported in a patient with migraine-triggered seizure, possibly due to 
supratentorial focal cerebral edema. Electroencephalogram (EEG) findings are usually normal 
interictal, although various abnormalities, mainly diffuse slowing, have been reported in 
migraineurs. [23] 
Symptom Migraine Epilepsy 
Duration of aura  15–60 min  Brief, often <1 min 
Automatisms  
 
Unusual  Frequent for complex partial 
seizures 
Gastrointestinal aura  Abdominal pain (rare) 
Nausea (common)  
‘‘Butterflies’’—rising 
epigastric sensation 
Visual disturbances  
 
Positive/negative  Complex visual phenomenon 
Paresthesias  Common (5–60 min)  Common (seconds to minutes) 
Altered consciousness  Usually responsive  Often unresponsive 
Olfactory  Very uncommon  More common 
Aphasia  Uncommon  Common 
D_ej_a vu  Rare  Common 
 
1.6 Probable migraine: Previously termed as a migrainous disorder, attacks and/or headache 
missing one of the features needed to fulfil the criteria for the disorders coded above.  
IHS CLASSIFICATION OF TENSION-TYPE HEADACHES –ICHD -2 
2.1 Infrequent episodic tension-type headache 
2.1.1  Infrequent episodic tension-type headache associated with pericranial 
tenderness 
2.1.2  Infrequent episodic tension-type headache not associated with pericranial 
tenderness 
2.2  Frequent episodic tension-type headache 
2.2.1  Frequent episodic tension-type headache associated with pericranial 
tenderness 
2.2.2  Frequent episodic tension-type headache not associated with pericranial 
tenderness 
2.3 Chronic tension-type headache 
2.3.1  Chronic tension-type headache associated with pericranial tenderness 
2.3.2  Chronic tension-type headache not associated with pericranial tenderness 
2.4 Probable tension-type headache 
2.4.1 Probable infrequent episodic tension-type headache 
2.4.2 Probable frequent episodic tension-type headache 
2.4.3 Probable chronic tension-type headache 
 
 
 
 
IHS DIAGNOSTIC CRITERIA FOR TENSION TYPE HEADACHES 
2.1 Infrequent episodic tension-type headache:  
Infrequent episodes of headache lasting minutes to days, the pain being typically bilateral, 
pressing or tightening in quality and of mild to moderate intensity, which does not worsen with 
routine physical activity, without nausea but photophobia or phonophobia may be present.  
Diagnostic criteria include (A) At least 10 episodes occurring on <1 day per month on average 
(<12 days per year) and fulfilling criteria B-D (B) Headache lasting from 30 minutes to 7 days 
(C) Headache has at least two of the following characteristics: (1) bilateral location (2) 
pressing/tightening (non-pulsating) quality (3) mild or moderate intensity (4) not aggravated by 
routine physical activity such as walking or climbing stairs (D) Both of the following: (1) no 
nausea or vomiting (anorexia may occur) (2) no more than one of photophobia or phonophobia 
(E) Not attributed to another disorder. 6 
2.1.1 Infrequent episodic tension-type headache associated with pericranial tenderness: 
Diagnostic criteria includes (A) Episodes fulfilling criteria A-E for 2.1 Infrequent episodic 
tension-type headache (B) Increased pericranial tenderness on manual palpation  
2.1.2 Infrequent episodic tension-type headache not associated with pericranial 
tenderness: Diagnostic criteria includes: (A) Episodes fulfilling criteria A-E for 2.1 Infrequent 
episodic tension-type headache (B) No increased pericranial tenderness. Increased pericranial 
tenderness recorded by manual palpation is the most significant abnormal finding in patients 
with tension-type headache. The tenderness increases with the intensity and frequency of 
headache and is further increased during actual headache. The diagnostic value of EMG and 
pressure algometry is limited Palpation is a useful guide for the treatment strategy. It also adds 
value and credibility to the explanations given to the patient. 
2.2 Frequent episodic tension-type headache:  
Frequent episodes of headache lasting minutes to days. The pain is typically bilateral, pressing or 
tightening in quality and of mild to moderate intensity, and it does not worsen with routine 
physical activity. There is no nausea but photophobia or phonophobia may be present. 
Diagnostic criteria include (A) At least 10 episodes occurring on ≥1 but <15 days per month for 
at least 3 months (≥12 and <180 days per year) and fulfilling criteria B-D (B) Headache lasting 
from 30 minutes to 7 days, (C) Headache has at least two of the following characteristics: 1. 
bilateral location, 2. pressing/tightening (non-pulsating) quality, 3. mild or moderate intensity, 4. 
not aggravated by routine physical activity such as walking or climbing stairs, (D) Both of the 
following: 1. no nausea or vomiting (anorexia may occur), 2. no more than one of photophobia 
or phonophobia, (E) Not attributed to another disorder. Frequent tension-type headache often 
coexists with migraine without aura. Coexisting tension-type headache in migraineurs should 
preferably be identified by a diagnostic headache diary. The treatment of migraine differs 
considerably from that of tension-type headache and it is important to educate patients to 
differentiate between these types of headaches in order to select the right treatment and to 
prevent medication-overuse headache. 
2.2.1 Frequent episodic tension-type headache associated with pericranial tenderness: 
Diagnostic criteria include: (A) Episodes fulfilling criteria A-E for 2.2 Frequent episodic tension-
type headache (B) Increased pericranial tenderness on manual palpation  
2.2.2 Frequent episodic tension-type headache not associated with pericranial tenderness: 
Diagnostic criteria include: (A) Episodes fulfilling criteria A-E for 2.2 Frequent episodic tension-
type headache (B) No increased pericranial tenderness 
 
2.3 Chronic tension-type headache 
This is a disorder evolving from episodic tension-type headache, with daily or very frequent 
episodes of headache lasting minutes to days. The pain is typically bilateral, pressing or 
tightening in quality and of mild to moderate intensity, and it does not worsen with routine 
physical activity. There may be mild nausea, photophobia or phonophobia. Diagnostic criteria: 
(A) Headache occurring on ≥15 days per month on average for >3 months (≥180 days per year)1 
and fulfilling criteria B-D (B) Headache lasts hours or may be continuous (C) Headache has at 
least two of the following characteristics: 1. bilateral location, 2. pressing/tightening (non-
pulsating) quality, 3. mild or moderate intensity 4. not aggravated by routine physical activity 
such as walking or climbing stairs (D) Both of the following: 1. no more than one of 
photophobia, phonophobia or mild nausea, 2. neither moderate or severe nausea nor vomiting, 
(E) Not attributed to another disorder 
When it is uncertain how many attacks fulfil one or other set of criteria it is strongly 
recommended to use a diagnostic headache diary prospectively. In many uncertain cases there is 
overuse of medication. When this fulfils criterion B for any of the subforms of 8.2 Medication-
overuse headache, the default rule is to code for 2.4.3 Probable chronic tension-type headache 
plus 8.2.8 Probable medication-overuse headache. When these criteria are still fulfilled 2 months 
after medication overuse has ceased, 2.3 Chronic tension-type headache should be diagnosed and 
8.2.8 Probable medication-overuse headache discarded. It should be remembered that some 
patients with chronic tension-type headache develop migraine-like features if they have severe 
pain and , conversely, some migraine patients develop increasingly frequent tension-type-like 
interval headaches, the nature of which remains unclear. 
2.3.1 Chronic tension-type headache associated with pericranial tenderness: Diagnostic 
criteria: (A) Headache fulfilling criteria A-E for 2.3 Chronic tension-type headache (B) Increased 
pericranial tenderness on manual palpation 
2.3.2 Chronic tension-type headache not associated with pericranial tenderness: 
Diagnostic criteria: (A) Headache fulfilling criteria A-E for 2.3 Chronic tension-type headache 
(B) No increased pericranial tenderness 
2.4 Probable tension-type headache 
Patients meeting one of these sets of criteria may also meet the criteria for one of the subforms of 
1.6 Probable migraine.  
2.4.1 Probable infrequent episodic tension-type headache: Diagnostic criteria: (A) Episodes 
fulfilling all but one of criteria A-D for 2.1 Infrequent episodic tension-type headache (B) 
Episodes do not fulfil criteria for 1.1 Migraine without aura (C) Not attributed to another 
disorder. 
2.4.2 Probable frequent episodic tension-type headache: Diagnostic criteria: (A) Episodes 
fulfilling all but one of criteria A-D for 2.2 Frequent episodic tension-type headache (B) 
Episodes do not fulfil criteria for 1.1 Migraine without aura (C) Not attributed to another 
disorder.  
2.4.3 Probable chronic tension-type headache: Diagnostic criteria: (A) Headache occurring 
on ≥15 days per month on average for >3 months (≥180 days per year) and fulfilling criteria B-
D, (B) Headache lasts hours or may be continuous (C) Headache has at least two of the following 
characteristics: 1. bilateral location, 2. pressing/tightening (non-pulsating) quality,  3. mild or 
moderate intensity, 4.not aggravated by routine physical activity such as walking or climbing 
stairs. (D) Both of the following: 1. no more than one of photophobia, phonophobia or mild 
nausea 
2. neither moderate or severe nausea nor vomiting (E) Not attributed to another disorder but there 
is, or has been within the last 2 months, medication overuse fulfilling criterion B for any of the 
subforms of 8.2 Medication-overuse headache 
IHC CLASSIFICATION –ICHD -2 
3.1 Cluster headache 
3.1.1 Episodic cluster headache 
3.1.2 Chronic cluster headache 
3.2 Paroxysmal hemicrania 
3.2.1 Episodic paroxysmal hemicrania 
3.2.2 Chronic paroxysmal hemicrania (CPH) 
 3.3 Short-lasting unilateral neuralgiform headache attacks with conjunctival injection 
and tearing (SUNCT) 
3.4 Probable trigeminal autonomic cephalalgia 
3.4.1 Probable cluster headache 
3.4.2 Probable paroxysmal hemicrania 
3.4.3 Probable SUNCT 
 IHS DIAGNOSTIC CRITERIA 
3.1 Cluster headache 
This entity presents with attacks of severe, strictly unilateral pain which is orbital, supraorbital, 
temporal or in any combination, lasting 15-180 minutes, occurring from once every other day to 
8 times a day. The attacks are associated with one or more of the following, all of which are 
ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhoea, forehead and facial 
sweating, miosis, ptosis, eyelid oedema. Most patients are restless or agitated during an attack. 
Diagnostic criteria: 
A. At least 5 attacks fulfilling criteria B-D 
B. Severe or very severe unilateral orbital, supraorbital and/or temporal pain  
lasting 15-180 minutes if untreated 
C. Headache is accompanied by at least one of the following:  
1) ipsilateral conjunctival injection and/or lacrimation, 2) ipsilateral nasal congestion 
and/or rhinorrhoea, 3) ipsilateral eyelid oedema, 4) ipsilateral forehead and facial 
sweating, 5) ipsilateral miosis and/or ptosis, 6) a sense of restlessness or agitation 
D.  Attacks have a frequency from one every other day to 8 per day 
E.  Not attributed to another disorder 
Acute attacks involve activation of the posterior hypothalamic grey matter. Cluster headache 
may be inherited (autosomal dominant) in about 5% of cases. Attacks usually occur in series 
(cluster periods) lasting for weeks or months separated by remission periods usually lasting 
months or years. However, about 10-15% of patients have chronic symptoms without remissions. 
Pain is maximal orbitally, supraorbitally, temporally or in any combination of these sites, but 
may spread to other regions of the head. Pain almost invariably recurs on the same side during an 
individual cluster period. During the worst attacks, the intensity of pain is excruciating. Patients 
are usually unable to lie down and characteristically pace the floor. Age at onset is usually 20-40 
years. For unknown reasons prevalence is 3-4 times higher in men than in women. Cluster 
headache with coexistent trigeminal neuralgia (cluster-tic syndrome): Some patients have been 
described who have both 3.1Cluster headache and 13.1Trigeminal neuralgia. They should 
receive both diagnoses. 
3.1.1 Episodic cluster headache: Cluster headache attacks occurring in periods lasting 7 days 
to 1 year separated by pain-free periods lasting 1 month or longer. Diagnostic criteria: (A) 
Attacks fulfilling criteria A-E for 3.1Cluster headache. (B) At least two cluster periods lasting 7-
365 days1 and separated by pain-free remission periods of ≥1 month.  
3.1.2 Chronic cluster headache: Cluster headache attacks occurring for more than 1 year 
without remission or with remissions lasting less than 1 month. Diagnostic criteria: (A) Attacks 
fulfilling criteria A-E for 3.1 Cluster headache, (B) Attacks recur over >1 year without remission 
periods or with remission periods lasting <1 month. Chronic cluster headache may arise de novo 
(previously referred to as primary chronic cluster headache) or evolve from the episodic subtype 
(previously referred to as secondary chronic cluster headache).  
3.2 Paroxysmal hemicranias They are shorter-lasting, more frequent, occur more 
commonly in females and respond absolutely to indomethacin. Diagnostic criteria: (A) At least 
20 attacks fulfilling criteria B-D, (B) Attacks of severe unilateral orbital, supraorbital or temporal 
pain lasting 2-30 minutes, (C) Headache is accompanied by at least one of the following: 1. 
ipsilateral conjunctival injection and/or lacrimation, 2. ipsilateral nasal congestion and/or 
rhinorrhoea, 3. ipsilateral eyelid oedema, 4. ipsilateral forehead and facial sweating, 5. ipsilateral 
miosis and/or ptosis; (D) Attacks have a frequency above 5 per day for more than half of the 
time, although periods with lower frequency may occur; (E) Attacks are prevented completely by 
therapeutic doses of indomethacin (F) Not attributed to another disorder. There is no male 
predominance. Onset is usually in adulthood, although childhood cases are reported. Paroxysmal 
hemicrania with coexistent trigeminal neuralgia: Patients who fulfil criteria for both 3.2 
Paroxysmal hemicrania and 13.1 Trigeminal neuralgia should receive both diagnoses. The 
importance of this observation is that both conditions require treatment. The pathophysiological 
significance of the association is not yet clear. 
3.2.1 Episodic paroxysmal hemicrania: Attacks of paroxysmal hemicrania occurring in 
periods lasting 7 days to 1 year separated by pain-free periods lasting ≥1 month. Diagnostic 
criteria: (A) Attacks fulfilling criteria A-F for 3.2 Paroxysmal hemicrania (B) At least two attack 
periods lasting 7-365 days and separated by pain-free remission periods of ≥1 month  
3.2.2 Chronic paroxysmal hemicrania (CPH): Attacks of paroxysmal hemicrania occurring 
for >1 year without remission or with remissions lasting <1 month. Diagnostic criteria: (A) 
Attacks fulfilling criteria A-F for 3.2 Paroxysmal hemicrania Attacks recur over >1 year without 
remission periods or with remission periods lasting <1 month 
3.3  Short-lasting unilateral neuralgiform headache attacks with conjunctival injection 
and tearing (SUNCT): This syndrome is characterised by short-lasting attacks of unilateral pain 
that are much briefer than those seen in any other TAC and very often accompanied by 
prominent lacrimation and redness of the ipsilateral eye. Diagnostic criteria: (A) At least 20 
attacks fulfilling criteria B-D; (B) Attacks of unilateral orbital, supraorbital or temporal stabbing 
or pulsating pain lasting 5-240 seconds; (C) Pain is accompanied by ipsilateral conjunctival 
injection and lacrimation; (D) Attacks occur with a frequency from 3 to 200 per day; (E) Not 
attributed to another disorder.Short-lasting Unilateral Neuralgiform headache attacks with cranial 
Autonomic symptoms (SUNA), is also described. The literature suggests that the most common 
mimics of SUNCT are lesions in the posterior fossa or involving the pituitary gland. SUNCT with 
coexistent trigeminal neuralgia: Patients have been described in whom there is an overlap 
between 3.3 SUNCT and 13.1 Trigeminal neuralgia. Such patients should receive both 
diagnoses. This differentiation is clinically difficult. 
3.4 Probable trigeminal autonomic cephalalgia 
Headache attacks that are believed to be a subtype of trigeminal autonomic cephalalgia but 
which do not quite meet the diagnostic criteria for any of the subtypes described above.  
3.4.1 Probable cluster headache: Diagnostic criteria: (A) Attacks fulfilling all but one of 
criteria A-D for 3.1 Cluster headache (B) Not attributed to another disorder 
3.4.2 Probable paroxysmal hemicrania: Diagnostic criteria: (A) Attacks fulfilling all but one 
of criteria A-E for 3.2 Paroxysmal hemicrania (B) Not attributed to another disorder 
3.4.3 Probable short-lasting unilateral neuralgiform headache attacks with conjunctival 
injection and tearing Diagnostic criteria: (A) Attacks fulfilling all but one of criteria A-D for 
3.3 Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing 
(SUNCT) (B) Not attributed to another disorder 
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